This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Burn and corrosion of hip and lower limb, except ankle and foot
ST19_BURN_CORROSION_HIP_LOWER_LIMB_ANKLE_FOOT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
962 |
4. Check minimum number of eventsNone |
962 |
5. Include endpointsNone |
962 |
6. Filter based on genotype QC (FinnGen only) |
934 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- T2[0-5]
- Name in latin
- Combustiones et corrosiones coxae, femoris et cruris
Similar endpoints
↥List of similar endpoints to
Burn and corrosion of hip and lower limb, except ankle and foot
based on the number of shared cases.
Similar with more cases:
- Burns and corrosions of external body surface, specified by site
- Burns and corrosions
- Injury, poisoning and certain other consequences of external causes
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 934 | 440 | 494 |
| Unadjusted period prevalence (%) | 0.19 | 0.16 | 0.23 |
| Median age at first event (years) | 48.29 | 40.41 | 55.32 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 962
- Matched controls
- 9620
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T24.2
ICD-10 Finland
Burn of second degree of hip and lower limb, except ankle and foot
2474.7
307.7
544
5
X12
ICD-10 Finland
Contact with other hot fluids
148.9
307.7
261
24
S14
ICPC
Burn/scald
21.4
307.7
273
175
T24.0
ICD-10 Finland
Burn of unspecified degree of hip and lower limb, except ankle and foot
2640.6
210.3
196
*
X18
ICD-10 Finland
Contact with other hot metals
100.2
206.0
107
12
QDD20
NOMESCO Finland
Excision of burn of lower limb and coverage
298.6
173.8
172
7
ZZA00
NOMESCO Finland
Split skin graft
17.2
169.1
147
100
T21.2
ICD-10 Finland
Burn of second degree of trunk
88.0
166.6
88
11
T24.3
ICD-10 Finland
Burn of third degree of hip and lower limb, except ankle and foot
+∞
161.1
150
*
T24.1
ICD-10 Finland
Burn of first degree of hip and lower limb, except ankle and foot
898.8
159.3
152
*
QDD00
NOMESCO Finland
Dressing of major burn of lower limb
229.7
136.7
138
7
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
8.2
94.6
136
190
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.9
89.0
236
596
T22.2
ICD-10 Finland
Burn of second degree of shoulder and upper limb, except wrist and hand
23.4
67.2
49
22
X59
ICD-10 Finland
Exposure to unspecified factor
3.2
57.1
304
1209
T23.2
ICD-10 Finland
Burn of second degree of wrist and hand
12.5
49.1
49
41
QBD00
NOMESCO Finland
Dressing of major burn of trunk
82.4
42.3
47
6
X58
ICD-10 Finland
Exposure to other specified factors
2.9
42.2
244
997
TQW10
NOMESCO Finland
Exchange of bandage for burn
153.5
42.1
44
*
QDD10
NOMESCO Finland
Debridement of burn of lower limb
425.1
41.5
41
*
T31.0
ICD-10 Finland
Burns involving less than 10% of body surface
73.0
37.2
42
6
QBD20
NOMESCO Finland
Excision of burn of trunk and coverage
83.5
36.1
40
5
X19
ICD-10 Finland
Contact with other and unspecified heat and hot substances
83.5
36.1
40
5
T21.0
ICD-10 Finland
Burn of unspecified degree of trunk
93.5
32.9
36
*
T31.1
ICD-10 Finland
Burns involving 10-19% of body surface
327.4
32.1
32
*
X14
ICD-10 Finland
Contact with hot air and gases
72.4
31.1
35
5
R4120
NOMESCO Finland
Occupational therapy
3.6
30.5
107
320
X09
ICD-10 Finland
Exposure to unspecified smoke, fire and flames
53.3
30.5
36
7
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.7
29.2
70
158
X06
ICD-10 Finland
Exposure to ignition or melting of other clothing and apparel
300.6
28.9
29
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.3
27.4
114
380
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.0
27.3
82
220
QCD20
NOMESCO Finland
Excision of burn of upper limb and coverage
47.2
26.6
32
7
T25.2
ICD-10 Finland
Burn of second degree of ankle and foot
25.9
25.4
35
14
T29.2
ICD-10 Finland
Burns of multiple regions, no more than second-degree burns mentioned
51.5
25.4
30
6
X00
ICD-10 Finland
Exposure to uncontrolled fire in building or structure
57.6
24.1
28
5
QCD00
NOMESCO Finland
Dressing of major burn of upper limb
38.7
24.0
30
8
T21.3
ICD-10 Finland
Burn of third degree of trunk
89.1
23.8
26
*
X04
ICD-10 Finland
Exposure to ignition of highly flammable material
123.0
22.7
24
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
21.3
320
1914
T24.4
ICD-10 Finland
Corrosion of unspecified degree of hip and lower limb, except ankle and foot
214.5
20.7
21
*
T25.3
ICD-10 Finland
Burn of third degree of ankle and foot
58.8
20.0
23
*
T29.3
ICD-10 Finland
Burns of multiple regions, at least one burn of third degree mentioned
+∞
19.9
19
*
W92
ICD-10 Finland
Exposure to excessive heat of man-made origin
29.6
19.7
26
9
X03
ICD-10 Finland
Exposure to controlled fire, not in building or structure
107.3
19.6
21
*
T24.5
ICD-10 Finland
Corrosion of first degree of hip and lower limb, except ankle and foot
+∞
18.8
18
*
T24
ICD-10 Finland
Burn and corrosion of hip and lower limb, except ankle and foot
183.2
17.6
18
*
T22.0
ICD-10 Finland
Burn of unspecified degree of shoulder and upper limb, except wrist and hand
32.1
17.1
22
7
J01DB01
ATC
cefalexin; oral
2.2
17.0
811
6857
T23.1
ICD-10 Finland
Burn of first degree of wrist and hand
22.3
16.9
24
11
N05AF03
ATC
chlorprothixene; systemic
4.2
16.2
43
105
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.1
16.0
45
115
QDB10, ,
SPAT
4.4
15.8
40
94
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
5.4
15.7
31
59
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.6
15.3
91
367
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.6
15.3
36
80
P15
ICPC
Chronic alcohol abuse
3.5
14.8
51
150
T20.2
ICD-10 Finland
Burn of second degree of head and neck
18.7
14.7
22
12
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.5
14.7
96
406
N02AX02
ATC
tramadol; systemic, rectal
1.7
14.5
395
2769
T22.3
ICD-10 Finland
Burn of third degree of shoulder and upper limb, except wrist and hand
43.2
14.1
17
*
N05AH03
ATC
olanzapine; systemic
2.6
14.1
88
364
T23.0
ICD-10 Finland
Burn of unspecified degree of wrist and hand
16.0
14.0
22
14
N05AH04
ATC
quetiapine; oral
1.9
14.0
207
1209
N03AX16
ATC
[U] pregabalin
1.9
13.5
205
1206
S01.0
ICD-10 Finland
Open wound of scalp
2.5
13.4
86
360
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
5.0
13.2
28
57
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
3.8
13.0
40
109
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
4.6
12.7
30
67
N07BB01
ATC
disulfiram; oral
2.9
12.6
61
221
T24.7
ICD-10 Finland
Corrosion of third degree of hip and lower limb, except ankle and foot
+∞
12.5
12
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
12.2
119
596
N18
ICPC
Paralysis/weakness
5.0
12.2
26
53
T21.1
ICD-10 Finland
Burn of first degree of trunk
18.3
12.1
18
10
T25.0
ICD-10 Finland
Burn of unspecified degree of ankle and foot
47.3
11.9
14
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.3
11.9
44
136
S18
ICPC
Laceration/cut
1.6
11.8
433
3232
N02BE01
ATC
paracetamol; systemic, rectal
2.0
11.7
835
7395
T95.3
ICD-10 Finland
Sequelae of burn, corrosion and frostbite of lower limb
65.8
11.6
13
*
QAD00
NOMESCO Finland
Dressing of major burn of head or neck
+∞
11.5
11
*
T29.0
ICD-10 Finland
Burns of multiple regions, unspecified degree
+∞
11.5
11
*
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.2
11.5
108
534
X76
ICD-10 Finland
Intentional self-harm by smoke, fire and flames
121.4
11.4
12
*
T30.0
ICD-10 Finland
Burn of unspecified body region, unspecified degree
17.3
11.2
17
10
AA1AD
NOMESCO Finland
CT of head and brain
1.7
11.2
246
1605
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
11.1
151
852
QBD10
NOMESCO Finland
Debridement of burn of trunk
43.8
10.9
13
*
N05AA02
ATC
levomepromazine; systemic
2.9
10.9
50
176
S97
ICPC
Chronic ulcer skin
2.6
10.8
66
270
ZXD05
NOMESCO Finland
Urgent procedure
1.7
10.7
285
1953
QXD00
NOMESCO Finland
Exchange of dressing for burn, unspecified location
60.7
10.6
12
*
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
5.1
10.6
22
44
T24.6
ICD-10 Finland
Corrosion of second degree of hip and lower limb, except ankle and foot
+∞
10.4
10
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.4
10.2
73
322
J01FF01
ATC
clindamycin; systemic
1.7
10.0
245
1638
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
9.9
151
882
TQW40
NOMESCO Finland
Remowal of suture of skin
2.4
9.8
71
314
P16
ICPC
Acute alcohol abuse
3.9
9.8
29
77
W19
ICD-10 Finland
Unspecified fall
2.1
9.7
101
519
ZZA40
NOMESCO Finland
Graft of synthetic skin substitute
55.6
9.7
11
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
9.6
389
2928
B18.2
ICD-10 Finland
Chronic viral hepatitis C
4.4
9.6
24
56
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
9.6
144
837
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
9.6
117
636
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.7
9.4
50
191
N05AX08
ATC
risperidone; systemic
2.1
9.4
90
448
N06AX11
ATC
mirtazapine; oral
1.6
9.2
308
2215
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
9.2
396
3013
Z46.3
ICD-10 Finland
Fitting and adjustment of dental prosthetic device
4.3
9.2
23
54
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.4
9.0
31
92
S82.1
ICD-10 Finland
Fracture of upper end of tibia
4.5
8.9
21
47
QDD00, ,
SPAT
50.5
8.7
10
*
N05BA01
ATC
diazepam; systemic, rectal
1.9
8.7
116
650
SPAT1254
SPAT
Administration of medicine
1.8
8.7
142
848
N05CD07
ATC
temazepam; oral
2.0
8.6
93
485
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.1
8.6
23
57
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.9
8.5
40
143
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.3
8.4
63
283
QCD10
NOMESCO Finland
Debridement of burn of upper limb
90.8
8.4
9
*
QDE25
NOMESCO Finland
Excision and repair of scar of lower limb caused by burn
90.8
8.4
9
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
8.4
109
605
A46
ICD-10 Finland
Erysipelas
1.8
8.3
132
780
N05BA04
ATC
oxazepam; oral
1.6
8.3
232
1595
NFH30
NOMESCO Finland
Reduction of dislocation prosthesis of hip joint, closed
10.9
8.3
15
14
N06AX21
ATC
duloxetine; oral
1.9
8.3
112
630
N28
ICPC
Limited function/disability (N)
4.3
8.2
21
50
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.7
8.2
25
68
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
8.1
131
778
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
4.1
8.1
22
55
T22.1
ICD-10 Finland
Burn of first degree of shoulder and upper limb, except wrist and hand
33.6
8.1
10
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
8.1
104
575
WX320
NOMESCO Finland
Spinalanesthesy
1.6
8.0
206
1388
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.4
8.0
28
84
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
6.7
7.9
19
29
ZXA10
NOMESCO Finland
Bilateral
1.7
7.9
151
941
N05BA02
ATC
chlordiazepoxide; systemic
3.2
7.9
30
95
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
10.9
7.8
14
13
F61.0
ICD-10 Finland
Mixed personality disorders
3.7
7.8
24
66
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
3.7
7.8
24
66
SPAT1260
SPAT
Consultation of another employee
1.7
7.7
155
978
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
6.4
7.7
19
30
T20.0
ICD-10 Finland
Burn of unspecified degree of head and neck
15.2
7.7
12
8
X01
ICD-10 Finland
Exposure to uncontrolled fire, not in building or structure
45.3
7.7
9
*
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
4.4
7.7
19
44
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
7.7
85
446
M54.5
ICD-10 Finland
Low back pain
1.5
7.6
328
2476
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.4
7.6
26
77
N05AX12
ATC
aripiprazole; systemic
2.4
7.5
52
226
S06.0
ICD-10 Finland
Concussion
1.8
7.5
112
650
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
7.5
65
312
XKC03
NOMESCO Finland
Water cystometry
3.2
7.4
28
88
T31.2
ICD-10 Finland
Burns involving 20-29% of body surface
80.7
7.4
8
*
U04
ICPC
Incontinence urine
2.4
7.3
49
210
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
7.3
89
483
T90.5
ICD-10 Finland
Sequelae of intracranial injury
4.2
7.3
19
46
ZY000
NOMESCO Finland
Hospital inpatient
3.9
7.3
21
55
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
7.2
137
851
Y94.8
ICD-10 Finland
Other leisure activity accident
2.9
7.2
34
122
W17
ICD-10 Finland
Other fall from one level to another
2.4
7.2
49
212
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.6
7.2
23
65
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
7.2
117
697
N03AG01
ATC
valproic acid; systemic, rectal
2.2
7.2
62
297
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
20.2
7.1
10
5
NFC00
NOMESCO Finland
Exchange of a loose part of prosthesis in hip joint
12.1
7.1
12
10
XKD03
NOMESCO Finland
Urethral pressure profilometry
3.9
7.0
20
52
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
4.4
7.0
17
39
R60.0
ICD-10 Finland
Localized oedema
1.8
7.0
100
573
N03AX09
ATC
lamotrigine; oral
2.2
6.9
58
274
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
6.9
288
2152
NB6AA
NOMESCO Finland
Humerus X-ray examination
3.4
6.9
24
72
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
6.9
97
553
N03AX12
ATC
[U] gabapentin; oral
1.7
6.8
131
816
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
6.8
95
539
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.1
6.8
27
88
P19
ICPC
Drug abuse
5.7
6.8
18
32
L28
ICPC
Limited function/disability (L)
1.7
6.8
141
898
Z3231
NOMESCO Finland
Registered nurse
1.5
6.8
238
1715
NFH10
NOMESCO Finland
Reduction of dislocation of hip joint, closed
16.8
6.8
10
6
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.3
6.7
25
78
ZXD35
NOMESCO Finland
Usual procedure
2.7
6.7
34
127
N05AN01
ATC
lithium; oral
2.8
6.7
32
116
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
6.7
59
285
T20.1
ICD-10 Finland
Burn of first degree of head and neck
22.7
6.7
9
*
R50.9
ICD-10 Finland
Fever, unspecified
1.7
6.7
145
934
M79.6
ICD-10 Finland
Pain in limb
1.4
6.6
372
2934
R41.0
ICD-10 Finland
Disorientation, unspecified
3.0
6.6
29
100
NG1AD
NOMESCO Finland
Knee CT examination
3.6
6.6
21
59
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
6.6
388
3089
S72.4
ICD-10 Finland
Fracture of lower end of femur
8.8
6.6
13
15
N05AB03
ATC
perphenazine; systemic, rectal
2.6
6.5
36
141
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.5
6.5
38
153
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.3
6.5
47
209
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.5
312
2390
W25
ICD-10 Finland
Contact with sharp glass
5.4
6.5
18
34
ZZA10
NOMESCO Finland
Split skin allograft
70.3
6.4
7
*
T95.1
ICD-10 Finland
Sequelae of burn, corrosion and frostbite of trunk
70.3
6.4
7
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.6
6.4
37
148
TNX30
NOMESCO Finland
Soft bandage, unspecified region
4.1
6.4
17
42
A02BC02
ATC
pantoprazole; systemic
1.4
6.3
572
4894
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.6
6.3
36
143
Z3226
NOMESCO Finland
Physiotherapist
1.6
6.3
151
995
R42
ICD-10 Finland
Dizziness and giddiness
1.6
6.3
178
1220
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
6.3
216
1545
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
6.3
325
2520
J01DA01
ATC
[U] cefalexin
1.4
6.2
528
4464
QXB99, ,
SPAT
2.8
6.2
29
104
W23
ICD-10 Finland
Caught, crushed, jammed or pinched in or between objects
4.0
6.2
17
43
R53
ICD-10 Finland
Malaise and fatigue
1.5
6.2
231
1682
Y94.0
ICD-10 Finland
Accident at home
3.4
6.2
21
62
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
6.1
106
642
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.2
6.1
51
241
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.1
381
3053
T23.3
ICD-10 Finland
Burn of third degree of wrist and hand
12.6
6.1
10
8
R52.2
ICD-10 Finland
Other chronic pain
2.5
6.1
36
146
R20.2
ICD-10 Finland
Paraesthesia of skin
2.0
6.1
68
359
J01CF05
ATC
flucloxacillin; systemic
1.9
6.1
75
410
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.2
6.0
23
73
W10
ICD-10 Finland
Fall on and from stairs and steps
2.2
6.0
50
236
ZXA00
NOMESCO Finland
Right side
1.5
6.0
197
1395
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
2.6
6.0
34
135
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
SPAT1148 [2001700249]
1.2e+00
1.2e+00
3.4e+00
1.0e+50
5.2e+00
2.7e+00
9.4e-01
cases:3.00%
controls:0.96%
cases:1.60%
controls:0.47%
cases:3.10%
controls:0.11%
cases:0.86%
controls:0.00%
cases:13.84%
controls:0.09%
cases:6.81%
controls:0.47%
cases:3.29%
controls:1.31%
28
89
906
9222
15
44
920
9277
29
10
906
9311
8
0
927
9321
128
8
797
9294
61
43
835
9038
26
104
765
7846
General Surgery
2 [38004447]
2 [38004447]
2.2e-01
4.7e-01
2.0e+00
6.7e+00
3.3e+00
1.1e+00
4.9e-01
cases:19.16%
controls:16.01%
cases:8.24%
controls:5.32%
cases:4.60%
controls:0.68%
cases:34.33%
controls:0.06%
cases:16.11%
controls:0.70%
cases:13.62%
controls:5.02%
cases:20.48%
controls:13.69%
179
1491
755
7820
77
496
858
8825
43
63
892
9258
321
6
614
9315
149
65
776
9237
122
456
774
8625
162
1088
629
6862
Exposure to unspecified factor
X59 [45756412]
X59 [45756412]
6.8e-01
1.2e+00
3.2e+00
—
4.1e+00
2.4e+00
1.0e+00
cases:3.96%
controls:2.04%
cases:2.46%
controls:0.73%
cases:2.25%
controls:0.10%
—
—
cases:5.30%
controls:0.10%
cases:5.80%
controls:0.54%
cases:6.07%
controls:2.26%
37
190
897
9121
23
68
912
9253
21
9
914
9312
—
49
9
876
9293
52
49
844
9032
48
180
743
7770
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
5.9e-01
9.6e-01
2.3e+00
1.0e+50
4.9e+00
3.1e+00
1.2e+00
cases:3.64%
controls:2.05%
cases:2.35%
controls:0.91%
cases:1.39%
controls:0.14%
cases:25.03%
controls:0.00%
cases:27.03%
controls:0.27%
cases:18.08%
controls:0.97%
cases:7.71%
controls:2.36%
34
191
900
9120
22
85
913
9236
13
13
922
9308
234
0
701
9321
250
25
675
9277
162
88
734
8993
61
188
730
7762
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
4.4e-01
4.8e-01
2.3e+00
4.0e+00
3.2e+00
8.0e-01
4.6e-01
cases:37.69%
controls:28.03%
cases:14.22%
controls:9.31%
cases:8.34%
controls:0.93%
cases:2.89%
controls:0.05%
cases:16.86%
controls:0.80%
cases:17.19%
controls:8.56%
cases:36.66%
controls:26.83%
352
2610
582
6701
133
868
802
8453
78
87
857
9234
27
5
908
9316
156
74
769
9228
154
777
742
8304
290
2133
501
5817
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
1.3e+00
1.8e+00
2.3e+00
1.0e+50
2.3e+00
1.9e+00
1.6e+00
cases:3.10%
controls:0.90%
cases:2.03%
controls:0.34%
cases:1.07%
controls:0.11%
cases:0.64%
controls:0.00%
cases:0.76%
controls:0.08%
cases:1.56%
controls:0.24%
cases:4.17%
controls:0.88%
29
84
905
9227
19
32
916
9289
10
10
925
9311
6
0
929
9321
7
7
918
9295
14
22
882
9059
33
70
758
7880
Exposure to other specified factors
X58 [45756411]
X58 [45756411]
1.0e+00
1.1e+00
2.6e+00
1.0e+50
4.4e+00
1.9e+00
8.9e-01
cases:4.18%
controls:1.56%
cases:1.28%
controls:0.42%
cases:0.86%
controls:0.06%
cases:6.84%
controls:0.00%
cases:4.00%
controls:0.05%
cases:3.01%
controls:0.48%
cases:4.42%
controls:1.87%
39
145
895
9166
12
39
923
9282
8
6
927
9315
64
0
871
9321
37
5
888
9297
27
44
869
9037
35
149
756
7801
Burn/scald
S14 [2002000979]
S14 [2002000979]
1.6e+00
2.5e+00
1.0e+50
1.0e+50
—
4.5e+00
1.6e+00
cases:0.96%
controls:0.20%
cases:0.75%
controls:0.06%
cases:6.10%
controls:0.00%
cases:2.89%
controls:0.00%
—
—
cases:6.36%
controls:0.08%
cases:1.52%
controls:0.30%
9
19
925
9292
7
6
928
9315
57
0
878
9321
27
0
908
9321
—
57
7
839
9074
12
24
779
7926
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.7e-01
3.7e-01
8.0e-01
4.9e+00
1.9e+00
4.8e-01
2.9e-01
cases:27.62%
controls:22.55%
cases:19.79%
controls:14.57%
cases:6.31%
controls:2.95%
cases:8.98%
controls:0.08%
cases:14.49%
controls:2.54%
cases:22.43%
controls:15.16%
cases:40.33%
controls:33.69%
258
2100
676
7211
185
1358
750
7963
59
275
876
9046
84
7
851
9314
134
236
791
9066
201
1377
695
7704
319
2678
472
5272
Psychiatry
26 [38004469]
26 [38004469]
8.8e-01
1.1e+00
1.3e+00
2.3e+00
1.1e+00
1.2e+00
1.0e+00
cases:12.85%
controls:5.75%
cases:8.13%
controls:2.93%
cases:3.85%
controls:1.11%
cases:0.75%
controls:0.08%
cases:3.57%
controls:1.20%
cases:9.38%
controls:2.90%
cases:14.66%
controls:5.70%
120
535
814
8776
76
273
859
9048
36
103
899
9218
7
7
928
9314
33
112
892
9190
84
263
812
8818
116
453
675
7497
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
M01AE01 [21603967]
2.9e-01
4.0e-01
1.4e+00
3.5e+00
2.1e+00
4.9e-01
4.1e-01
cases:39.51%
controls:32.77%
cases:20.11%
controls:14.48%
cases:5.67%
controls:1.52%
cases:2.89%
controls:0.09%
cases:14.70%
controls:2.04%
cases:22.10%
controls:14.79%
cases:44.75%
controls:34.94%
369
3051
565
6260
188
1350
747
7971
53
142
882
9179
27
8
908
9313
136
190
789
9112
198
1343
698
7738
354
2778
437
5172
ibuprofen
R02AX02 [1588667]
R02AX02 [1588667]
2.9e-01
4.0e-01
1.4e+00
3.5e+00
2.1e+00
4.9e-01
4.1e-01
cases:39.51%
controls:32.77%
cases:20.11%
controls:14.48%
cases:5.67%
controls:1.52%
cases:2.89%
controls:0.09%
cases:14.70%
controls:2.04%
cases:22.10%
controls:14.79%
cases:44.75%
controls:34.94%
369
3051
565
6260
188
1350
747
7971
53
142
882
9179
27
8
908
9313
136
190
789
9112
198
1343
698
7738
354
2778
437
5172
Poisoning by systemic antibiotics
T36 [45756588]
T36 [45756588]
1.6e+00
1.9e+00
—
—
—
2.7e+00
2.3e+00
cases:2.25%
controls:0.46%
cases:1.28%
controls:0.20%
—
—
—
—
—
—
cases:1.45%
controls:0.10%
cases:3.54%
controls:0.38%
21
43
913
9268
12
19
923
9302
—
—
—
13
9
883
9072
28
30
763
7920
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
6.9e-01
9.2e-01
1.8e+00
—
2.7e+00
1.1e+00
7.8e-01
cases:5.89%
controls:3.03%
cases:2.67%
controls:1.08%
cases:0.96%
controls:0.16%
—
—
cases:2.16%
controls:0.15%
cases:3.46%
controls:1.20%
cases:8.98%
controls:4.34%
55
282
879
9029
25
101
910
9220
9
15
926
9306
—
20
14
905
9288
31
109
865
8972
71
345
720
7605
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
Y83 [45552036]
1.2e+00
2.1e+00
—
—
—
2.6e+00
1.6e+00
cases:1.50%
controls:0.46%
cases:1.39%
controls:0.17%
—
—
—
—
—
—
cases:1.23%
controls:0.09%
cases:1.90%
controls:0.39%
14
43
920
9268
13
16
922
9305
—
—
—
11
8
885
9073
15
31
776
7919
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
5.3e-01
8.0e-01
1.7e+00
—
2.8e+00
9.6e-01
5.3e-01
cases:11.35%
controls:6.98%
cases:4.81%
controls:2.23%
cases:2.14%
controls:0.41%
—
—
cases:5.30%
controls:0.35%
cases:5.13%
controls:2.04%
cases:9.86%
controls:6.08%
106
650
828
8661
45
208
890
9113
20
38
915
9283
—
49
33
876
9269
46
185
850
8896
78
483
713
7467
Emergency Room Visit
ER [9203]
ER [9203]
5.4e-01
8.4e-01
2.0e+00
—
2.3e+00
8.5e-01
6.4e-01
cases:44.54%
controls:31.89%
cases:22.89%
controls:11.32%
cases:9.73%
controls:1.44%
—
—
cases:13.62%
controls:1.52%
cases:21.65%
controls:10.57%
cases:44.63%
controls:29.85%
416
2969
518
6342
214
1055
721
8266
91
134
844
9187
—
126
141
799
9161
194
960
702
8121
353
2373
438
5577
General Practice
1 [38004446]
1 [38004446]
6.6e-01
8.6e-01
1.6e+00
—
2.5e+00
9.0e-01
6.5e-01
cases:19.27%
controls:11.01%
cases:10.27%
controls:4.61%
cases:3.64%
controls:0.78%
—
—
cases:8.11%
controls:0.69%
cases:10.27%
controls:4.44%
cases:21.74%
controls:12.68%
180
1025
754
8286
96
430
839
8891
34
73
901
9248
—
75
64
850
9238
92
403
804
8678
172
1008
619
6942
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
4.2e-01
5.9e-01
5.6e-01
4.1e+00
1.1e+00
5.7e-01
4.3e-01
cases:11.03%
controls:7.56%
cases:7.06%
controls:4.03%
cases:2.35%
controls:1.36%
cases:3.64%
controls:0.06%
cases:3.89%
controls:1.37%
cases:6.81%
controls:3.95%
cases:13.27%
controls:9.08%
103
704
831
8607
66
376
869
8945
22
127
913
9194
34
6
901
9315
36
127
889
9175
61
359
835
8722
105
722
686
7228
Unspecified nonorganic psychosis
F29 [45533099]
F29 [45533099]
1.1e+00
—
2.3e+00
—
2.0e+00
1.9e+00
1.7e+00
cases:1.50%
controls:0.50%
—
—
cases:0.64%
controls:0.06%
—
—
cases:0.54%
controls:0.08%
cases:1.45%
controls:0.21%
cases:1.77%
controls:0.31%
14
47
920
9264
—
6
6
929
9315
—
5
7
920
9295
13
19
883
9062
14
25
777
7925
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
QDB10 [2001309970]
1.2e+00
1.8e+00
—
1.0e+50
—
3.4e+00
1.8e+00
cases:1.07%
controls:0.33%
cases:0.86%
controls:0.14%
—
—
cases:2.03%
controls:0.00%
—
—
cases:3.91%
controls:0.13%
cases:2.02%
controls:0.34%
10
31
924
9280
8
13
927
9308
—
19
0
916
9321
—
35
12
861
9069
16
27
775
7923
Chronic viral hepatitis C
B18.2 [45590846]
B18.2 [45590846]
1.8e+00
2.2e+00
—
—
—
—
3.1e+00
cases:0.96%
controls:0.16%
cases:0.64%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.08%
9
15
925
9296
6
7
929
9314
—
—
—
—
13
6
778
7944
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.4e-01
2.0e-01
8.0e-01
4.4e+00
1.5e+00
2.7e-01
3.2e-01
cases:26.34%
controls:23.78%
cases:21.28%
controls:18.10%
cases:7.27%
controls:3.39%
cases:7.91%
controls:0.11%
cases:12.86%
controls:3.09%
cases:22.99%
controls:18.59%
cases:42.86%
controls:35.27%
246
2214
688
7097
199
1687
736
7634
68
316
867
9005
74
10
861
9311
119
287
806
9015
206
1688
690
7393
339
2804
452
5146
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
5.8e-01
8.1e-01
1.8e+00
1.0e+50
2.4e+00
8.4e-01
5.0e-01
cases:6.42%
controls:3.68%
cases:4.28%
controls:1.94%
cases:1.60%
controls:0.26%
cases:3.21%
controls:0.00%
cases:2.59%
controls:0.24%
cases:5.02%
controls:2.24%
cases:10.49%
controls:6.64%
60
343
874
8968
40
181
895
9140
15
24
920
9297
30
0
905
9321
24
22
901
9280
45
203
851
8878
83
528
708
7422
Laceration/cut
S18 [2002000983]
S18 [2002000983]
4.9e-01
6.5e-02
1.7e+00
—
3.5e+00
1.2e+00
3.9e-01
cases:9.10%
controls:5.80%
cases:2.14%
controls:2.01%
cases:1.60%
controls:0.29%
—
—
cases:7.03%
controls:0.24%
cases:7.03%
controls:2.17%
cases:10.75%
controls:7.55%
85
540
849
8771
20
187
915
9134
15
27
920
9294
—
65
22
860
9280
63
197
833
8884
85
600
706
7350
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
1.2e-01
5.4e-01
2.5e+00
—
3.6e+00
5.1e-01
8.1e-01
cases:4.50%
controls:4.01%
cases:1.93%
controls:1.13%
cases:0.75%
controls:0.06%
—
—
cases:2.38%
controls:0.06%
cases:1.67%
controls:1.01%
cases:6.70%
controls:3.11%
42
373
892
8938
18
105
917
9216
7
6
928
9315
—
22
6
903
9296
15
92
881
8989
53
247
738
7703
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.3e-01
2.2e-01
8.2e-01
4.2e+00
1.6e+00
2.7e-01
3.1e-01
cases:26.45%
controls:23.99%
cases:21.82%
controls:18.28%
cases:7.49%
controls:3.43%
cases:7.91%
controls:0.13%
cases:13.19%
controls:3.11%
cases:23.21%
controls:18.81%
cases:42.86%
controls:35.58%
247
2234
687
7077
204
1704
731
7617
70
320
865
9001
74
12
861
9309
122
289
803
9013
208
1708
688
7373
339
2829
452
5121
Paranoid schizophrenia continuous
F20.00 [2000501920]
F20.00 [2000501920]
1.4e+00
1.9e+00
—
—
1.6e+00
1.8e+00
1.8e+00
cases:1.07%
controls:0.26%
cases:0.86%
controls:0.13%
—
—
—
—
cases:0.54%
controls:0.11%
cases:0.89%
controls:0.15%
cases:1.26%
controls:0.21%
10
24
924
9287
8
12
927
9309
—
—
5
10
920
9292
8
14
888
9067
10
17
781
7933
Internal Medicine
11 [38004456]
11 [38004456]
2.4e-01
4.6e-01
9.1e-01
3.7e+00
8.3e-01
5.1e-01
4.5e-01
cases:23.66%
controls:19.53%
cases:12.30%
controls:8.11%
cases:3.64%
controls:1.49%
cases:2.57%
controls:0.06%
cases:3.03%
controls:1.34%
cases:12.61%
controls:7.98%
cases:26.30%
controls:18.52%
221
1818
713
7493
115
756
820
8565
34
139
901
9182
24
6
911
9315
28
125
897
9177
113
725
783
8356
208
1472
583
6478
Orthopedic Surgery
20 [38004465]
20 [38004465]
6.0e-01
9.4e-01
1.2e+00
—
2.4e+00
1.0e+00
7.1e-01
cases:18.95%
controls:11.33%
cases:10.48%
controls:4.38%
cases:2.35%
controls:0.74%
—
—
cases:6.92%
controls:0.67%
cases:10.94%
controls:4.22%
cases:23.26%
controls:12.97%
177
1055
757
8256
98
408
837
8913
22
69
913
9252
—
64
62
861
9240
98
383
798
8698
184
1031
607
6919
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
8.5e-02
2.0e-01
6.8e-01
4.2e+00
1.3e+00
3.0e-01
2.5e-01
cases:28.16%
controls:26.47%
cases:24.49%
controls:20.92%
cases:8.24%
controls:4.37%
cases:7.91%
controls:0.13%
cases:13.84%
controls:4.00%
cases:27.46%
controls:21.92%
cases:46.27%
controls:40.04%
263
2465
671
6846
229
1950
706
7371
77
407
858
8914
74
12
861
9309
128
372
797
8930
246
1991
650
7090
366
3183
425
4767
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
1.8e+00
1.6e+00
—
—
—
2.5e+00
2.4e+00
cases:2.14%
controls:0.34%
cases:0.86%
controls:0.18%
—
—
—
—
—
—
cases:0.78%
controls:0.07%
cases:2.78%
controls:0.25%
20
32
914
9279
8
17
927
9304
—
—
—
7
6
889
9075
22
20
769
7930
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
2.2e-01
2.1e-01
6.6e-01
4.0e+00
1.4e+00
3.5e-01
3.3e-01
cases:21.41%
controls:18.01%
cases:17.11%
controls:14.39%
cases:5.67%
controls:3.00%
cases:4.49%
controls:0.09%
cases:10.16%
controls:2.75%
cases:20.09%
controls:15.09%
cases:35.40%
controls:28.19%
200
1677
734
7634
160
1341
775
7980
53
280
882
9041
42
8
893
9313
94
256
831
9046
180
1370
716
7711
280
2241
511
5709
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
4.0e-02
2.4e-01
5.5e-01
4.3e+00
1.5e+00
3.3e-01
2.5e-01
cases:25.80%
controls:25.05%
cases:20.43%
controls:16.78%
cases:5.35%
controls:3.14%
cases:5.78%
controls:0.09%
cases:10.49%
controls:2.54%
cases:21.88%
controls:16.69%
cases:41.72%
controls:35.81%
241
2332
693
6979
191
1564
744
7757
50
293
885
9028
54
8
881
9313
97
236
828
9066
196
1516
700
7565
330
2847
461
5103
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-6.5e-01
-7.2e-01
—
—
2.8e+00
2.2e+00
3.0e+00
cases:14.88%
controls:25.01%
cases:4.06%
controls:8.00%
—
—
—
—
cases:0.86%
controls:0.05%
cases:3.68%
controls:0.44%
cases:16.43%
controls:0.97%
139
2329
795
6982
38
746
897
8575
—
—
8
5
917
9297
33
40
863
9041
130
77
661
7873
Inpatient Hospital
21 [8717]
21 [8717]
4.2e-01
5.9e-01
1.7e+00
—
2.5e+00
8.3e-01
4.7e-01
cases:39.61%
controls:30.21%
cases:16.58%
controls:9.92%
cases:6.52%
controls:1.29%
—
—
cases:15.68%
controls:1.44%
cases:18.19%
controls:8.84%
cases:33.25%
controls:23.74%
370
2813
564
6498
155
925
780
8396
61
120
874
9201
—
145
134
780
9168
163
803
733
8278
263
1887
528
6063
Outpatient Hospital
22 [8756]
22 [8756]
2.9e-01
5.2e-01
1.4e+00
—
2.8e+00
8.0e-01
6.6e-01
cases:28.37%
controls:22.85%
cases:10.48%
controls:6.51%
cases:2.99%
controls:0.77%
—
—
cases:11.46%
controls:0.75%
cases:11.83%
controls:5.70%
cases:28.07%
controls:16.74%
265
2128
669
7183
98
607
837
8714
28
72
907
9249
—
106
70
819
9232
106
518
790
8563
222
1331
569
6619
Emergency Medicine
93 [38004510]
93 [38004510]
5.4e-01
7.8e-01
1.8e+00
—
2.1e+00
8.3e-01
4.5e-01
cases:17.02%
controls:10.70%
cases:11.98%
controls:5.88%
cases:4.81%
controls:0.82%
—
—
cases:5.73%
controls:0.76%
cases:13.28%
controls:6.27%
cases:24.65%
controls:17.31%
159
996
775
8315
112
548
823
8773
45
76
890
9245
—
53
71
872
9231
119
569
777
8512
195
1376
596
6574
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
2.6e-01
7.7e-01
—
1.0e+50
3.2e+00
2.1e+00
1.2e+00
cases:2.68%
controls:2.07%
cases:1.18%
controls:0.55%
—
—
cases:1.50%
controls:0.00%
cases:2.49%
controls:0.11%
cases:3.01%
controls:0.40%
cases:4.30%
controls:1.37%
25
193
909
9118
11
51
924
9270
—
14
0
921
9321
23
10
902
9292
27
36
869
9045
34
109
757
7841
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
1.4e-01
2.3e-01
7.0e-01
2.9e+00
1.7e+00
5.4e-01
5.5e-01
cases:30.51%
controls:27.61%
cases:17.75%
controls:14.62%
cases:4.92%
controls:2.51%
cases:1.71%
controls:0.10%
cases:12.54%
controls:2.61%
cases:22.43%
controls:14.46%
cases:47.28%
controls:34.00%
285
2571
649
6740
166
1363
769
7958
46
234
889
9087
16
9
919
9312
116
243
809
9059
201
1313
695
7768
374
2703
417
5247
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
7.8e-01
9.2e-01
—
—
4.1e+00
1.4e+00
3.1e-01
cases:3.43%
controls:1.60%
cases:1.71%
controls:0.69%
—
—
—
—
cases:3.89%
controls:0.06%
cases:2.34%
controls:0.62%
cases:3.03%
controls:2.25%
32
149
902
9162
16
64
919
9257
—
—
36
6
889
9296
21
56
875
9025
24
179
767
7771
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
3.6e-02
1.8e-01
5.7e-01
4.0e+00
1.3e+00
2.7e-01
2.0e-01
cases:30.62%
controls:29.86%
cases:27.81%
controls:24.36%
cases:9.20%
controls:5.41%
cases:8.34%
controls:0.17%
cases:15.57%
controls:4.75%
cases:31.25%
controls:25.70%
cases:50.32%
controls:45.28%
286
2780
648
6531
260
2271
675
7050
86
504
849
8817
78
16
857
9305
144
442
781
8860
280
2334
616
6747
398
3600
393
4350
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
3.5e-02
1.8e-01
5.7e-01
4.0e+00
1.3e+00
2.7e-01
2.0e-01
cases:30.62%
controls:29.89%
cases:27.81%
controls:24.40%
cases:9.20%
controls:5.43%
cases:8.34%
controls:0.17%
cases:15.57%
controls:4.74%
cases:31.25%
controls:25.72%
cases:50.32%
controls:45.31%
286
2783
648
6528
260
2274
675
7047
86
506
849
8815
78
16
857
9305
144
441
781
8861
280
2336
616
6745
398
3602
393
4348
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
3.5e-02
1.8e-01
5.7e-01
4.0e+00
1.3e+00
2.7e-01
2.0e-01
cases:30.62%
controls:29.89%
cases:27.81%
controls:24.40%
cases:9.20%
controls:5.42%
cases:8.34%
controls:0.17%
cases:15.57%
controls:4.75%
cases:31.25%
controls:25.75%
cases:50.32%
controls:45.32%
286
2783
648
6528
260
2274
675
7047
86
505
849
8816
78
16
857
9305
144
442
781
8860
280
2338
616
6743
398
3603
393
4347
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
3.8e-02
1.7e-01
5.7e-01
4.0e+00
1.3e+00
2.7e-01
2.0e-01
cases:30.73%
controls:29.93%
cases:27.81%
controls:24.44%
cases:9.20%
controls:5.42%
cases:8.34%
controls:0.17%
cases:15.57%
controls:4.76%
cases:31.25%
controls:25.76%
cases:50.44%
controls:45.33%
287
2787
647
6524
260
2278
675
7043
86
505
849
8816
78
16
857
9305
144
443
781
8859
280
2339
616
6742
399
3604
392
4346
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
3.5e-02
1.8e-01
5.7e-01
4.0e+00
1.3e+00
2.7e-01
2.0e-01
cases:30.62%
controls:29.88%
cases:27.81%
controls:24.35%
cases:9.20%
controls:5.42%
cases:8.34%
controls:0.17%
cases:15.57%
controls:4.75%
cases:31.14%
controls:25.72%
cases:50.32%
controls:45.30%
286
2782
648
6529
260
2270
675
7051
86
505
849
8816
78
16
857
9305
144
442
781
8860
279
2336
617
6745
398
3601
393
4349
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
3.5e-02
1.7e-01
5.5e-01
4.0e+00
1.3e+00
2.8e-01
2.0e-01
cases:30.62%
controls:29.89%
cases:27.81%
controls:24.45%
cases:9.09%
controls:5.44%
cases:8.34%
controls:0.17%
cases:15.68%
controls:4.78%
cases:31.47%
controls:25.79%
cases:50.32%
controls:45.37%
286
2783
648
6528
260
2279
675
7042
85
507
850
8814
78
16
857
9305
145
445
780
8857
282
2342
614
6739
398
3607
393
4343
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
3.9e-02
1.8e-01
5.6e-01
4.0e+00
1.3e+00
2.7e-01
2.1e-01
cases:30.62%
controls:29.79%
cases:27.70%
controls:24.32%
cases:9.09%
controls:5.40%
cases:8.34%
controls:0.17%
cases:15.46%
controls:4.73%
cases:31.14%
controls:25.61%
cases:50.32%
controls:45.11%
286
2774
648
6537
259
2267
676
7054
85
503
850
8818
78
16
857
9305
143
440
782
8862
279
2326
617
6755
398
3586
393
4364
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
4.9e-02
6.1e-02
5.5e-01
4.2e+00
1.3e+00
2.2e-01
1.3e-01
cases:19.91%
controls:19.14%
cases:15.94%
controls:15.14%
cases:6.20%
controls:3.69%
cases:5.35%
controls:0.09%
cases:10.16%
controls:3.06%
cases:19.20%
controls:16.07%
cases:31.86%
controls:29.18%
186
1782
748
7529
149
1411
786
7910
58
344
877
8977
50
8
885
9313
94
285
831
9017
172
1459
724
7622
252
2320
539
5630
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
4.3e-01
6.1e-01
—
—
3.8e+00
1.5e+00
6.9e-01
cases:2.57%
controls:1.69%
cases:1.18%
controls:0.64%
—
—
—
—
cases:3.78%
controls:0.09%
cases:2.57%
controls:0.61%
cases:3.92%
controls:2.01%
24
157
910
9154
11
60
924
9261
—
—
35
8
890
9294
23
55
873
9026
31
160
760
7790
Outpatient Visit
OP [9202]
OP [9202]
1.1e-01
1.5e-01
3.2e-01
3.1e+00
1.8e+00
7.0e-01
3.2e-01
cases:68.31%
controls:65.89%
cases:49.20%
controls:45.36%
cases:13.37%
controls:10.10%
cases:9.52%
controls:0.48%
cases:37.84%
controls:9.52%
cases:62.95%
controls:45.78%
cases:79.77%
controls:74.16%
638
6135
296
3176
460
4228
475
5093
125
941
810
8380
89
45
846
9276
350
886
575
8416
564
4157
332
4924
631
5896
160
2054
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
5.7e-01
2.9e-01
—
—
3.3e+00
1.1e+00
7.1e-01
cases:5.25%
controls:3.05%
cases:1.07%
controls:0.80%
—
—
—
—
cases:2.59%
controls:0.10%
cases:2.68%
controls:0.88%
cases:5.82%
controls:2.96%
49
284
885
9027
10
75
925
9246
—
—
24
9
901
9293
24
80
872
9001
46
235
745
7715
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
5.4e-01
9.7e-02
1.6e+00
1.0e+50
2.2e+00
7.2e-01
6.3e-01
cases:7.07%
controls:4.23%
cases:1.82%
controls:1.65%
cases:0.96%
controls:0.19%
cases:2.35%
controls:0.00%
cases:1.51%
controls:0.17%
cases:3.35%
controls:1.66%
cases:9.48%
controls:5.30%
66
394
868
8917
17
154
918
9167
9
18
926
9303
22
0
913
9321
14
16
911
9286
30
151
866
8930
75
421
716
7529
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
-6.5e-02
3.7e-02
5.2e-01
3.8e+00
1.2e+00
8.9e-02
1.0e-03
cases:21.52%
controls:22.64%
cases:17.43%
controls:16.91%
cases:6.20%
controls:3.77%
cases:6.10%
controls:0.14%
cases:10.05%
controls:3.32%
cases:19.20%
controls:17.85%
cases:34.51%
controls:34.49%
201
2108
733
7203
163
1576
772
7745
58
351
877
8970
57
13
878
9308
93
309
832
8993
172
1621
724
7460
273
2742
518
5208
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
9.5e-01
9.3e-01
1.4e+00
—
1.2e+00
1.1e+00
1.1e+00
cases:6.00%
controls:2.41%
cases:3.64%
controls:1.47%
cases:1.50%
controls:0.38%
—
—
cases:1.08%
controls:0.34%
cases:4.13%
controls:1.37%
cases:6.95%
controls:2.43%
56
224
878
9087
34
137
901
9184
14
35
921
9286
—
10
32
915
9270
37
124
859
8957
55
193
736
7757
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
3.1e-01
5.3e-01
—
1.0e+50
3.8e+00
8.8e-01
7.9e-01
cases:7.60%
controls:5.70%
cases:2.57%
controls:1.53%
—
—
cases:1.82%
controls:0.00%
cases:2.27%
controls:0.05%
cases:3.01%
controls:1.28%
cases:8.09%
controls:3.84%
71
531
863
8780
24
143
911
9178
—
17
0
918
9321
21
5
904
9297
27
116
869
8965
64
305
727
7645
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
2.7e-01
3.6e-01
3.9e-01
4.1e+00
1.0e+00
2.3e-01
3.4e-01
cases:15.10%
controls:11.96%
cases:8.88%
controls:6.34%
cases:1.71%
controls:1.17%
cases:2.99%
controls:0.05%
cases:2.49%
controls:0.91%
cases:8.26%
controls:6.66%
cases:20.61%
controls:15.62%
141
1114
793
8197
83
591
852
8730
16
109
919
9212
28
5
907
9316
23
85
902
9217
74
605
822
8476
163
1242
628
6708
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
5.1e-01
5.5e-01
1.5e+00
—
2.3e+00
4.2e-01
4.9e-01
cases:17.88%
controls:11.61%
cases:7.70%
controls:4.61%
cases:2.99%
controls:0.65%
—
—
cases:5.62%
controls:0.62%
cases:6.81%
controls:4.58%
cases:19.85%
controls:13.21%
167
1081
767
8230
72
430
863
8891
28
61
907
9260
—
52
58
873
9244
61
416
835
8665
157
1050
634
6900
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
3.5e-01
3.2e-01
—
1.0e+50
3.2e+00
1.1e+00
1.0e+00
cases:4.39%
controls:3.13%
cases:1.28%
controls:0.93%
—
—
cases:1.71%
controls:0.00%
cases:2.05%
controls:0.09%
cases:1.90%
controls:0.63%
cases:5.18%
controls:1.97%
41
291
893
9020
12
87
923
9234
—
16
0
919
9321
19
8
906
9294
17
57
879
9024
41
157
750
7793
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
6.7e-02
1.0e-01
6.0e-01
3.6e+00
1.1e+00
1.9e-01
2.0e-01
cases:58.14%
controls:56.50%
cases:51.34%
controls:48.74%
cases:29.84%
controls:18.99%
cases:29.52%
controls:1.12%
cases:42.27%
controls:19.61%
cases:56.03%
controls:51.27%
cases:73.07%
controls:69.02%
543
5261
391
4050
480
4543
455
4778
279
1770
656
7551
276
104
659
9217
391
1824
534
7478
502
4656
394
4425
578
5487
213
2463
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
6.6e-01
9.1e-01
7.5e-01
—
1.2e+00
1.5e+00
8.8e-01
cases:6.32%
controls:3.36%
cases:3.74%
controls:1.54%
cases:1.18%
controls:0.56%
—
—
cases:1.62%
controls:0.51%
cases:5.47%
controls:1.28%
cases:8.09%
controls:3.53%
59
313
875
8998
35
144
900
9177
11
52
924
9269
—
15
47
910
9255
49
116
847
8965
64
281
727
7669
gabapentin; oral
N02BF01 [955005]
N02BF01 [955005]
8.8e-01
8.4e-01
1.3e+00
—
9.9e-01
1.1e+00
8.8e-01
cases:4.28%
controls:1.83%
cases:2.57%
controls:1.13%
cases:1.39%
controls:0.36%
—
—
cases:0.97%
controls:0.37%
cases:3.68%
controls:1.20%
cases:7.08%
controls:3.07%
40
170
894
9141
24
105
911
9216
13
34
922
9287
—
9
34
916
9268
33
109
863
8972
56
244
735
7706
Withdrawal symptoms caused by alcohol UNS
F10.39 [2000501687]
F10.39 [2000501687]
2.4e+00
—
—
—
—
—
2.6e+00
cases:0.86%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.08%
8
7
926
9304
—
—
—
—
—
8
6
783
7944
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
1.2e+00
1.2e+00
1.1e+00
—
1.1e+00
1.3e+00
1.3e+00
cases:3.00%
controls:0.92%
cases:2.14%
controls:0.68%
cases:0.96%
controls:0.31%
—
—
cases:0.76%
controls:0.26%
cases:2.68%
controls:0.72%
cases:4.17%
controls:1.13%
28
86
906
9225
20
63
915
9258
9
29
926
9292
—
7
24
918
9278
24
65
872
9016
33
90
758
7860
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
4.4e-01
6.2e-01
1.2e+00
9.6e-01
1.5e+00
9.4e-01
6.4e-01
cases:6.10%
controls:4.02%
cases:4.49%
controls:2.46%
cases:2.25%
controls:0.71%
cases:0.64%
controls:0.25%
cases:2.92%
controls:0.65%
cases:6.14%
controls:2.49%
cases:11.76%
controls:6.55%
57
374
877
8937
42
229
893
9092
21
66
914
9255
6
23
929
9298
27
60
898
9242
55
226
841
8855
93
521
698
7429
buspirone; oral
N05BE01 [21604601]
N05BE01 [21604601]
—
1.8e+00
—
—
—
2.2e+00
2.7e+00
—
—
cases:0.53%
controls:0.09%
—
—
—
—
—
—
cases:0.67%
controls:0.08%
cases:1.52%
controls:0.10%
—
5
8
930
9313
—
—
—
6
7
890
9074
12
8
779
7942
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
5.4e-01
6.5e-01
2.0e+00
1.0e+50
2.4e+00
6.2e-01
4.6e-01
cases:5.78%
controls:3.45%
cases:3.10%
controls:1.64%
cases:1.28%
controls:0.18%
cases:1.60%
controls:0.00%
cases:2.16%
controls:0.20%
cases:2.79%
controls:1.52%
cases:7.08%
controls:4.60%
54
321
880
8990
29
153
906
9168
12
17
923
9304
15
0
920
9321
20
19
905
9283
25
138
871
8943
56
366
735
7584
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
6.2e-01
—
—
1.0e+50
—
3.6e+00
1.3e+00
cases:1.07%
controls:0.58%
—
—
—
—
cases:1.71%
controls:0.00%
—
—
cases:4.91%
controls:0.14%
cases:1.90%
controls:0.53%
10
54
924
9257
—
—
16
0
919
9321
—
44
13
852
9068
15
42
776
7908
Chronic ulcer skin
S97 [2002001061]
S97 [2002001061]
1.4e+00
1.2e+00
—
—
—
2.2e+00
1.3e+00
cases:1.18%
controls:0.29%
cases:0.75%
controls:0.24%
—
—
—
—
—
—
cases:1.79%
controls:0.21%
cases:2.28%
controls:0.63%
11
27
923
9284
7
22
928
9299
—
—
—
16
19
880
9062
18
50
773
7900
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
8.6e-01
1.6e+00
—
—
—
1.4e+00
9.3e-01
cases:2.57%
controls:1.11%
cases:1.82%
controls:0.38%
—
—
—
—
—
—
cases:1.79%
controls:0.43%
cases:3.16%
controls:1.27%
24
103
910
9208
17
35
918
9286
—
—
—
16
39
880
9042
25
101
766
7849
zolpidem; oral
N05CF02 [21604655]
N05CF02 [21604655]
1.0e+00
7.8e-01
1.4e+00
—
—
8.6e-01
7.1e-01
cases:6.10%
controls:2.30%
cases:2.78%
controls:1.30%
cases:1.07%
controls:0.26%
—
—
—
—
cases:2.90%
controls:1.24%
cases:5.44%
controls:2.74%
57
214
877
9097
26
121
909
9200
10
24
925
9297
—
—
26
113
870
8968
43
218
748
7732
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
8.7e-01
7.0e-01
—
1.0e+50
2.8e+00
1.1e+00
7.0e-01
cases:2.57%
controls:1.10%
cases:1.18%
controls:0.59%
—
—
cases:0.86%
controls:0.00%
cases:1.51%
controls:0.10%
cases:1.67%
controls:0.55%
cases:2.91%
controls:1.47%
24
102
910
9209
11
55
924
9266
—
8
0
927
9321
14
9
911
9293
15
50
881
9031
23
117
768
7833
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
3.9e-02
1.4e-01
4.3e-01
3.4e+00
9.0e-01
2.1e-01
1.1e-01
cases:35.01%
controls:34.13%
cases:34.44%
controls:31.45%
cases:14.01%
controls:9.57%
cases:11.12%
controls:0.41%
cases:20.65%
controls:9.58%
cases:38.28%
controls:33.36%
cases:53.48%
controls:50.79%
327
3178
607
6133
322
2931
613
6390
131
892
804
8429
104
38
831
9283
191
891
734
8411
343
3029
553
6052
423
4038
368
3912
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
3.5e-01
6.3e-01
2.1e+00
1.0e+50
3.0e+00
1.1e+00
7.1e-01
cases:7.49%
controls:5.41%
cases:2.46%
controls:1.33%
cases:0.53%
controls:0.06%
cases:2.03%
controls:0.00%
cases:2.05%
controls:0.11%
cases:3.24%
controls:1.16%
cases:7.21%
controls:3.69%
70
504
864
8807
23
124
912
9197
5
6
930
9315
19
0
916
9321
19
10
906
9292
29
105
867
8976
57
293
734
7657
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
2.4e-01
2.6e-01
—
1.0e+50
3.5e+00
7.9e-01
1.2e+00
cases:6.21%
controls:4.95%
cases:1.60%
controls:1.24%
—
—
cases:2.99%
controls:0.00%
cases:2.81%
controls:0.09%
cases:2.01%
controls:0.93%
cases:9.48%
controls:3.19%
58
461
876
8850
15
116
920
9205
—
28
0
907
9321
26
8
899
9294
18
84
878
8997
75
254
716
7696
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
5.8e-02
2.3e-01
1.6e+00
—
3.0e+00
6.9e-01
2.2e-01
cases:4.93%
controls:4.66%
cases:2.57%
controls:2.06%
cases:1.18%
controls:0.24%
—
—
cases:3.78%
controls:0.19%
cases:3.24%
controls:1.65%
cases:7.59%
controls:6.16%
46
434
888
8877
24
192
911
9129
11
22
924
9299
—
35
18
890
9284
29
150
867
8931
60
490
731
7460
loperamide; oral
A07DA03 [21600646]
A07DA03 [21600646]
5.7e-01
1.5e+00
2.2e+00
—
—
7.6e-01
9.8e-01
cases:1.39%
controls:0.79%
cases:1.28%
controls:0.30%
cases:0.64%
controls:0.08%
—
—
—
—
cases:0.89%
controls:0.42%
cases:2.02%
controls:0.77%
13
74
921
9237
12
28
923
9293
6
7
929
9314
—
—
8
38
888
9043
16
61
775
7889
loperamide oxide; oral
A07DA05 [21600648]
A07DA05 [21600648]
5.7e-01
1.5e+00
2.2e+00
—
—
7.6e-01
9.8e-01
cases:1.39%
controls:0.79%
cases:1.28%
controls:0.30%
cases:0.64%
controls:0.08%
—
—
—
—
cases:0.89%
controls:0.42%
cases:2.02%
controls:0.77%
13
74
921
9237
12
28
923
9293
6
7
929
9314
—
—
8
38
888
9043
16
61
775
7889
Severe psychotic and other severe mental disorders
112 [2001600112]
112 [2001600112]
8.8e-01
—
—
—
—
2.6e+00
1.9e+00
cases:1.18%
controls:0.49%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.07%
cases:1.90%
controls:0.28%
11
46
923
9265
—
—
—
—
8
6
888
9075
15
22
776
7928
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
1.9e-01
3.2e-01
1.4e+00
1.0e+50
3.1e+00
1.4e+00
5.2e-01
cases:4.50%
controls:3.75%
cases:1.82%
controls:1.33%
cases:0.75%
controls:0.18%
cases:1.93%
controls:0.00%
cases:3.46%
controls:0.16%
cases:4.13%
controls:1.00%
cases:5.69%
controls:3.47%
42
349
892
8962
17
124
918
9197
7
17
928
9304
18
0
917
9321
32
15
893
9287
37
91
859
8990
45
276
746
7674
disulfiram; oral
N07BB01 [21604821]
N07BB01 [21604821]
1.3e+00
1.8e+00
—
—
—
1.2e+00
1.5e+00
cases:2.03%
controls:0.58%
cases:1.39%
controls:0.24%
—
—
—
—
—
—
cases:1.00%
controls:0.30%
cases:2.65%
controls:0.63%
19
54
915
9257
13
22
922
9299
—
—
—
9
27
887
9054
21
50
770
7900
levomepromazine; oral, parenteral
N05AA02 [21604493]
N05AA02 [21604493]
1.1e+00
1.6e+00
—
—
—
1.3e+00
1.7e+00
cases:1.50%
controls:0.50%
cases:1.18%
controls:0.24%
—
—
—
—
—
—
cases:0.89%
controls:0.25%
cases:2.15%
controls:0.42%
14
47
920
9264
11
22
924
9299
—
—
—
8
23
888
9058
17
33
774
7917
Infectious Disease
44 [38004484]
44 [38004484]
7.7e-01
1.0e+00
—
—
2.0e+00
1.6e+00
5.3e-01
cases:3.21%
controls:1.51%
cases:1.50%
controls:0.55%
—
—
—
—
cases:0.65%
controls:0.09%
cases:2.34%
controls:0.50%
cases:2.65%
controls:1.57%
30
141
904
9170
14
51
921
9270
—
—
6
8
919
9294
21
45
875
9036
21
125
770
7825
Revision of wound of skin of lower limb
QDB05 [2001309969]
QDB05 [2001309969]
2.5e+00
—
—
1.0e+50
1.0e+50
—
1.8e+00
cases:1.07%
controls:0.09%
—
—
—
—
cases:1.07%
controls:0.00%
cases:0.76%
controls:0.00%
—
—
cases:1.01%
controls:0.16%
10
8
924
9303
—
—
10
0
925
9321
7
0
918
9302
—
8
13
783
7937
Open wound of scalp
S01.0 [45592468]
S01.0 [45592468]
1.3e+00
2.0e+00
—
—
—
—
1.1e+00
cases:1.93%
controls:0.56%
cases:0.86%
controls:0.12%
—
—
—
—
—
—
—
—
cases:2.40%
controls:0.81%
18
52
916
9259
8
11
927
9310
—
—
—
—
19
64
772
7886
Primary arthrosis of other joints
M19.0 [45601353]
M19.0 [45601353]
9.7e-01
1.6e+00
—
—
—
1.8e+00
8.1e-01
cases:1.71%
controls:0.66%
cases:1.50%
controls:0.30%
—
—
—
—
—
—
cases:1.45%
controls:0.25%
cases:1.77%
controls:0.79%
16
61
918
9250
14
28
921
9293
—
—
—
13
23
883
9058
14
63
777
7887
Guidance concerning treatment of rash and skin
SPAT1156 [2001700257]
SPAT1156 [2001700257]
6.4e-01
9.0e-01
—
—
2.3e+00
1.2e+00
8.1e-01
cases:2.57%
controls:1.37%
cases:1.28%
controls:0.53%
—
—
—
—
cases:0.76%
controls:0.08%
cases:1.45%
controls:0.46%
cases:2.91%
controls:1.32%
24
128
910
9183
12
49
923
9272
—
—
7
7
918
9295
13
42
883
9039
23
105
768
7845
Mixed personality disorders
F61.0 [2000502024]
F61.0 [2000502024]
1.9e+00
2.0e+00
—
—
—
2.3e+00
—
cases:0.75%
controls:0.11%
cases:0.53%
controls:0.08%
—
—
—
—
—
—
cases:0.56%
controls:0.06%
—
—
7
10
927
9301
5
7
930
9314
—
—
—
5
5
891
9076
—
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
3.7e-01
7.2e-01
—
1.0e+50
1.5e+00
1.4e+00
6.1e-01
cases:7.39%
controls:5.20%
cases:3.74%
controls:1.87%
—
—
cases:0.53%
controls:0.00%
cases:1.30%
controls:0.29%
cases:7.59%
controls:1.93%
cases:10.49%
controls:5.99%
69
484
865
8827
35
174
900
9147
—
5
0
930
9321
12
27
913
9275
68
175
828
8906
83
476
708
7474
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
3.9e-01
4.9e-01
1.0e+00
—
2.2e+00
1.1e+00
5.6e-01
cases:12.74%
controls:9.00%
cases:4.17%
controls:2.60%
cases:1.07%
controls:0.39%
—
—
cases:3.57%
controls:0.41%
cases:7.25%
controls:2.51%
cases:11.88%
controls:7.14%
119
838
815
8473
39
242
896
9079
10
36
925
9285
—
33
38
892
9264
65
228
831
8853
94
568
697
7382
Striking against or struck by other object(s)
W22 [45756260]
W22 [45756260]
1.2e+00
1.5e+00
—
1.0e+50
2.1e+00
1.8e+00
1.1e+00
cases:1.71%
controls:0.54%
cases:0.75%
controls:0.16%
—
—
cases:1.71%
controls:0.00%
cases:0.54%
controls:0.06%
cases:0.89%
controls:0.14%
cases:2.40%
controls:0.81%
16
50
918
9261
7
15
928
9306
—
16
0
919
9321
5
6
920
9296
8
13
888
9068
19
64
772
7886
Schizophrenia, unspecified
F20.9 [45576533]
F20.9 [45576533]
2.3e+00
—
—
—
—
1.9e+00
1.8e+00
cases:1.39%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.09%
cases:1.14%
controls:0.19%
13
13
921
9298
—
—
—
—
5
8
891
9073
9
15
782
7935
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
OMOP4821991 [45756751]
1.1e+00
1.6e+00
—
—
—
1.4e+00
1.4e+00
cases:2.03%
controls:0.72%
cases:0.96%
controls:0.19%
—
—
—
—
—
—
cases:1.00%
controls:0.25%
cases:2.91%
controls:0.70%
19
67
915
9244
9
18
926
9303
—
—
—
9
23
887
9058
23
56
768
7894
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
8.7e-01
1.2e+00
—
—
2.2e+00
1.9e+00
6.9e-01
cases:1.93%
controls:0.82%
cases:1.18%
controls:0.36%
—
—
—
—
cases:0.65%
controls:0.08%
cases:1.79%
controls:0.26%
cases:1.64%
controls:0.83%
18
76
916
9235
11
34
924
9287
—
—
6
7
919
9295
16
24
880
9057
13
66
778
7884
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
3.1e-01
1.6e-01
1.1e+00
1.0e+50
3.2e+00
7.8e-01
3.2e-01
cases:4.28%
controls:3.18%
cases:1.82%
controls:1.56%
cases:0.64%
controls:0.21%
cases:1.82%
controls:0.00%
cases:3.03%
controls:0.13%
cases:2.79%
controls:1.30%
cases:5.82%
controls:4.28%
40
296
894
9015
17
145
918
9176
6
20
929
9301
17
0
918
9321
28
12
897
9290
25
118
871
8963
46
340
745
7610
Post-traumatic stress disorder
F43.1 [45595909]
F43.1 [45595909]
—
—
—
—
—
2.2e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.08%
cases:1.26%
controls:0.23%
—
—
—
—
—
6
7
890
9074
10
18
781
7932
Addiction caused by alcohol UNS
F10.29 [2000501684]
F10.29 [2000501684]
1.8e+00
—
—
—
—
2.1e+00
2.1e+00
cases:1.07%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.07%
cases:1.39%
controls:0.18%
10
17
924
9294
—
—
—
—
5
6
891
9075
11
14
780
7936
Mechanical complication of internal joint prosthesis
T84.0 [45570736]
T84.0 [45570736]
1.6e+00
—
1.0e+50
1.0e+50
—
—
2.3e+00
cases:1.18%
controls:0.25%
—
—
cases:0.75%
controls:0.00%
cases:0.75%
controls:0.00%
—
—
—
—
cases:1.90%
controls:0.20%
11
23
923
9288
—
7
0
928
9321
7
0
928
9321
—
—
15
16
776
7934
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
N05AB03 [21604502]
1.6e+00
1.8e+00
—
—
—
1.6e+00
2.2e+00
cases:1.28%
controls:0.26%
cases:0.64%
controls:0.11%
—
—
—
—
—
—
cases:0.56%
controls:0.11%
cases:1.64%
controls:0.19%
12
24
922
9287
6
10
929
9311
—
—
—
5
10
891
9071
13
15
778
7935
Inpatient Visit
IP [9201]
IP [9201]
2.8e-01
3.7e-01
8.7e-01
—
3.1e+00
7.2e-01
4.3e-01
cases:6.00%
controls:4.60%
cases:2.46%
controls:1.71%
cases:0.53%
controls:0.23%
—
—
cases:3.35%
controls:0.16%
cases:3.79%
controls:1.88%
cases:8.34%
controls:5.58%
56
428
878
8883
23
159
912
9162
5
21
930
9300
—
31
15
894
9287
34
171
862
8910
66
444
725
7506
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
8.5e-01
8.4e-01
1.2e+00
—
—
9.1e-01
1.2e+00
cases:5.03%
controls:2.21%
cases:2.35%
controls:1.03%
cases:0.64%
controls:0.20%
—
—
—
—
cases:2.23%
controls:0.91%
cases:6.07%
controls:1.95%
47
206
887
9105
22
96
913
9225
6
19
929
9302
—
—
20
83
876
8998
48
155
743
7795
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
7.4e-01
1.3e+00
—
1.0e+50
2.5e+00
7.5e-01
3.9e-01
cases:2.46%
controls:1.19%
cases:1.71%
controls:0.48%
—
—
cases:0.53%
controls:0.00%
cases:0.76%
controls:0.06%
cases:1.12%
controls:0.53%
cases:2.28%
controls:1.56%
23
111
911
9200
16
45
919
9276
—
5
0
930
9321
7
6
918
9296
10
48
886
9033
18
124
773
7826
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
1.9e-01
1.7e-01
1.1e+00
—
2.9e+00
7.3e-01
3.4e-01
cases:8.35%
controls:7.01%
cases:3.74%
controls:3.18%
cases:1.28%
controls:0.44%
—
—
cases:4.86%
controls:0.27%
cases:5.02%
controls:2.49%
cases:12.14%
controls:8.96%
78
653
856
8658
35
296
900
9025
12
41
923
9280
—
45
25
880
9277
45
226
851
8855
96
712
695
7238
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
7.6e-01
7.9e-01
3.2e-01
—
4.0e-01
1.1e+00
1.1e+00
cases:5.78%
controls:2.78%
cases:4.17%
controls:1.93%
cases:0.75%
controls:0.55%
—
—
cases:0.86%
controls:0.58%
cases:5.25%
controls:1.89%
cases:9.48%
controls:3.50%
54
259
880
9052
39
180
896
9141
7
51
928
9270
—
8
54
917
9248
47
172
849
8909
75
278
716
7672
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
4.3e-01
9.9e-01
—
—
2.4e+00
1.2e+00
7.4e-01
cases:1.82%
controls:1.19%
cases:1.28%
controls:0.48%
—
—
—
—
cases:0.97%
controls:0.09%
cases:1.56%
controls:0.48%
cases:3.16%
controls:1.53%
17
111
917
9200
12
45
923
9276
—
—
9
8
916
9294
14
44
882
9037
25
122
766
7828
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
3.2e-01
3.1e-01
—
—
3.6e+00
5.7e-01
3.5e-01
cases:2.46%
controls:1.80%
cases:1.07%
controls:0.78%
—
—
—
—
cases:1.95%
controls:0.05%
cases:1.34%
controls:0.76%
cases:3.79%
controls:2.69%
23
168
911
9143
10
73
925
9248
—
—
18
5
907
9297
12
69
884
9012
30
214
761
7736
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
7.2e-01
1.3e+00
—
1.0e+50
2.3e+00
7.8e-01
4.0e-01
cases:2.14%
controls:1.05%
cases:1.60%
controls:0.45%
—
—
cases:0.53%
controls:0.00%
cases:0.65%
controls:0.06%
cases:1.00%
controls:0.46%
cases:2.02%
controls:1.36%
20
98
914
9213
15
42
920
9279
—
5
0
930
9321
6
6
919
9296
9
42
887
9039
16
108
775
7842
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
2.7e-01
5.9e-01
1.1e+00
—
1.5e+00
3.8e-01
4.4e-01
cases:12.21%
controls:9.58%
cases:8.13%
controls:4.69%
cases:1.82%
controls:0.63%
—
—
cases:2.59%
controls:0.61%
cases:6.70%
controls:4.69%
cases:19.60%
controls:13.56%
114
892
820
8419
76
437
859
8884
17
59
918
9262
—
24
57
901
9245
60
426
836
8655
155
1078
636
6872
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
4.2e-01
1.1e+00
—
1.0e+50
2.5e+00
9.6e-01
2.2e-01
cases:2.57%
controls:1.71%
cases:1.50%
controls:0.51%
—
—
cases:2.67%
controls:0.00%
cases:0.76%
controls:0.06%
cases:1.56%
controls:0.61%
cases:2.28%
controls:1.84%
24
159
910
9152
14
48
921
9273
—
25
0
910
9321
7
6
918
9296
14
55
882
9026
18
146
773
7804
chlorprothixene; oral, parenteral
N05AF03 [21604533]
N05AF03 [21604533]
1.7e+00
1.5e+00
—
—
—
1.8e+00
1.6e+00
cases:1.50%
controls:0.27%
cases:0.64%
controls:0.15%
—
—
—
—
—
—
cases:1.00%
controls:0.17%
cases:1.01%
controls:0.21%
14
25
920
9286
6
14
929
9307
—
—
—
9
15
887
9066
8
17
783
7933
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
6.2e-01
1.0e+00
—
1.0e+50
2.5e+00
8.2e-01
4.1e-01
cases:2.46%
controls:1.34%
cases:1.50%
controls:0.54%
—
—
cases:0.64%
controls:0.00%
cases:0.76%
controls:0.06%
cases:1.34%
controls:0.59%
cases:2.65%
controls:1.79%
23
125
911
9186
14
50
921
9271
—
6
0
929
9321
7
6
918
9296
12
54
884
9027
21
142
770
7808
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
6.2e-01
1.0e+00
—
1.0e+50
2.5e+00
8.0e-01
3.7e-01
cases:2.46%
controls:1.34%
cases:1.50%
controls:0.54%
—
—
cases:0.64%
controls:0.00%
cases:0.76%
controls:0.06%
cases:1.34%
controls:0.61%
cases:2.53%
controls:1.76%
23
125
911
9186
14
50
921
9271
—
6
0
929
9321
7
6
918
9296
12
55
884
9026
20
140
771
7810
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
6.2e-01
1.0e+00
—
1.0e+50
2.5e+00
8.2e-01
4.1e-01
cases:2.46%
controls:1.34%
cases:1.50%
controls:0.54%
—
—
cases:0.64%
controls:0.00%
cases:0.76%
controls:0.06%
cases:1.34%
controls:0.59%
cases:2.65%
controls:1.79%
23
125
911
9186
14
50
921
9271
—
6
0
929
9321
7
6
918
9296
12
54
884
9027
21
142
770
7808
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
4.1e-01
3.8e-01
1.8e+00
—
2.6e+00
8.6e-01
4.9e-01
cases:5.25%
controls:3.53%
cases:1.71%
controls:1.18%
cases:0.64%
controls:0.11%
—
—
cases:1.62%
controls:0.12%
cases:2.23%
controls:0.96%
cases:5.82%
controls:3.64%
49
329
885
8982
16
110
919
9211
6
10
929
9311
—
15
11
910
9291
20
87
876
8994
46
289
745
7661
zopiclone; oral
N05CF01 [21604654]
N05CF01 [21604654]
4.8e-01
4.2e-01
9.2e-01
—
9.2e-01
5.8e-01
5.7e-01
cases:9.31%
controls:5.95%
cases:5.45%
controls:3.66%
cases:2.35%
controls:0.95%
—
—
cases:2.27%
controls:0.91%
cases:6.47%
controls:3.72%
cases:10.37%
controls:6.16%
87
554
847
8757
51
341
884
8980
22
89
913
9232
—
21
85
904
9217
58
338
838
8743
82
490
709
7460
Chronic alcohol abuse
P15 [2002000811]
P15 [2002000811]
1.5e+00
2.1e+00
—
—
—
—
1.4e+00
cases:0.96%
controls:0.23%
cases:1.18%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.43%
9
21
925
9290
11
14
924
9307
—
—
—
—
13
34
778
7916
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
3.1e-01
3.8e-01
4.0e-01
1.6e+00
1.0e+00
3.2e-01
5.7e-01
cases:94.11%
controls:92.12%
cases:85.13%
controls:79.59%
cases:49.95%
controls:39.98%
cases:10.05%
controls:2.20%
cases:64.11%
controls:39.06%
cases:84.82%
controls:80.29%
cases:96.33%
controls:93.69%
879
8577
55
734
796
7419
139
1902
467
3727
468
5594
94
205
841
9116
593
3633
332
5669
760
7291
136
1790
762
7448
29
502
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
5.6e-01
1.0e+00
—
1.0e+50
2.3e+00
8.2e-01
4.0e-01
cases:2.36%
controls:1.36%
cases:1.50%
controls:0.54%
—
—
cases:0.64%
controls:0.00%
cases:0.65%
controls:0.06%
cases:1.34%
controls:0.59%
cases:2.65%
controls:1.80%
22
127
912
9184
14
50
921
9271
—
6
0
929
9321
6
6
919
9296
12
54
884
9027
21
143
770
7807
Primary coxarthrosis, bilateral
M16.0 [45543482]
M16.0 [45543482]
1.4e+00
1.8e+00
—
—
—
—
-1.5e-02
cases:1.71%
controls:0.41%
cases:1.07%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.64%
16
38
918
9273
10
16
925
9305
—
—
—
—
5
51
786
7899
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.1e-01
2.0e-01
3.7e-01
2.9e+00
4.4e-01
2.9e-01
2.4e-01
cases:27.19%
controls:25.16%
cases:21.60%
controls:18.45%
cases:4.71%
controls:3.30%
cases:0.96%
controls:0.05%
cases:4.86%
controls:3.20%
cases:24.44%
controls:19.43%
cases:44.25%
controls:38.36%
254
2343
680
6968
202
1720
733
7601
44
308
891
9013
9
5
926
9316
45
298
880
9004
219
1764
677
7317
350
3050
441
4900
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
1.6e-01
8.8e-01
—
1.0e+50
3.2e+00
8.8e-01
4.9e-01
cases:3.32%
controls:2.84%
cases:1.71%
controls:0.72%
—
—
cases:0.96%
controls:0.00%
cases:1.73%
controls:0.08%
cases:1.45%
controls:0.61%
cases:4.42%
controls:2.75%
31
264
903
9047
16
67
919
9254
—
9
0
926
9321
16
7
909
9295
13
55
883
9026
35
219
756
7731
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
6.8e-01
6.2e-01
—
—
2.4e+00
6.3e-01
4.2e-02
cases:3.53%
controls:1.82%
cases:1.28%
controls:0.70%
—
—
—
—
cases:0.97%
controls:0.09%
cases:1.00%
controls:0.54%
cases:2.53%
controls:2.43%
33
169
901
9142
12
65
923
9256
—
—
9
8
916
9294
9
49
887
9032
20
193
771
7757
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
2.0e-01
4.9e-02
—
—
3.1e+00
6.3e-01
2.0e-01
cases:1.71%
controls:1.41%
cases:0.64%
controls:0.61%
—
—
—
—
cases:1.41%
controls:0.06%
cases:1.00%
controls:0.54%
cases:2.53%
controls:2.09%
16
131
918
9180
6
57
929
9264
—
—
13
6
912
9296
9
49
887
9032
20
166
771
7784
oxycodone and naloxone; oral
N02AA55 [21604265]
N02AA55 [21604265]
3.6e-01
3.2e-01
—
—
1.9e+00
1.2e+00
6.6e-02
cases:1.82%
controls:1.28%
cases:0.96%
controls:0.70%
—
—
—
—
cases:0.76%
controls:0.12%
cases:2.34%
controls:0.70%
cases:2.40%
controls:2.25%
17
119
917
9192
9
65
926
9256
—
—
7
11
918
9291
21
64
875
9017
19
179
772
7771
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
8.0e-01
9.7e-01
—
1.0e+50
—
1.3e+00
3.9e-01
cases:2.57%
controls:1.17%
cases:1.71%
controls:0.65%
—
—
cases:0.86%
controls:0.00%
—
—
cases:2.12%
controls:0.59%
cases:3.03%
controls:2.08%
24
109
910
9202
16
61
919
9260
—
8
0
927
9321
—
19
54
877
9027
24
165
767
7785
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
4.4e-01
1.2e-01
—
—
2.1e+00
7.2e-01
9.6e-01
cases:2.68%
controls:1.74%
cases:0.75%
controls:0.67%
—
—
—
—
cases:1.08%
controls:0.14%
cases:1.67%
controls:0.83%
cases:4.80%
controls:1.89%
25
162
909
9149
7
62
928
9259
—
—
10
13
915
9289
15
75
881
9006
38
150
753
7800
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
4.9e-01
4.9e-01
9.2e-01
—
1.8e+00
7.2e-01
3.9e-01
cases:8.35%
controls:5.29%
cases:2.25%
controls:1.38%
cases:0.53%
controls:0.21%
—
—
cases:1.30%
controls:0.22%
cases:3.46%
controls:1.72%
cases:7.21%
controls:4.98%
78
493
856
8818
21
129
914
9192
5
20
930
9301
—
12
20
913
9282
31
156
865
8925
57
396
734
7554
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
2.4e-01
5.5e-01
9.7e-01
—
1.9e+00
1.1e+00
4.7e-01
cases:5.25%
controls:4.17%
cases:2.57%
controls:1.50%
cases:0.53%
controls:0.20%
—
—
cases:1.62%
controls:0.24%
cases:2.68%
controls:0.94%
cases:4.80%
controls:3.04%
49
388
885
8923
24
140
911
9181
5
19
930
9302
—
15
22
910
9280
24
85
872
8996
38
242
753
7708
paroxetine; oral
N06AB05 [21604713]
N06AB05 [21604713]
5.5e-01
1.5e+00
—
—
—
1.4e+00
7.5e-01
cases:1.07%
controls:0.62%
cases:1.28%
controls:0.29%
—
—
—
—
—
—
cases:1.12%
controls:0.26%
cases:1.26%
controls:0.60%
10
58
924
9253
12
27
923
9294
—
—
—
10
24
886
9057
10
48
781
7902
Erysipelas
A46 [45561706]
A46 [45561706]
8.0e-01
6.0e-01
2.2e+00
—
—
6.5e-01
6.6e-01
cases:3.32%
controls:1.53%
cases:0.86%
controls:0.47%
cases:0.64%
controls:0.08%
—
—
—
—
cases:1.34%
controls:0.70%
cases:3.16%
controls:1.66%
31
142
903
9169
8
44
927
9277
6
7
929
9314
—
—
12
64
884
9017
25
132
766
7818
Aid fitting and borrowing and monitoring of use
SPAT1230 [2001700331]
SPAT1230 [2001700331]
8.3e-01
1.1e+00
—
—
—
1.0e+00
6.8e-01
cases:3.43%
controls:1.53%
cases:1.93%
controls:0.68%
—
—
—
—
—
—
cases:1.67%
controls:0.61%
cases:3.79%
controls:1.96%
32
142
902
9169
18
63
917
9258
—
—
—
15
55
881
9026
30
156
761
7794
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
6.4e-01
7.1e-01
1.0e+00
—
1.1e+00
1.0e+00
5.6e-01
cases:7.17%
controls:3.93%
cases:3.96%
controls:1.98%
cases:1.28%
controls:0.46%
—
—
cases:1.19%
controls:0.42%
cases:4.91%
controls:1.86%
cases:8.09%
controls:4.77%
67
366
867
8945
37
185
898
9136
12
43
923
9278
—
11
39
914
9263
44
169
852
8912
64
379
727
7571
Chronic ulcer of skin, not elsewhere classified
L98.4 [45533667]
L98.4 [45533667]
—
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.08%
—
—
—
—
—
—
9
6
782
7944
Bipolar affective disorder, unspecified
F31.9 [45571758]
F31.9 [45571758]
1.1e+00
2.7e+00
—
—
—
—
1.1e+00
cases:0.96%
controls:0.31%
cases:0.96%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.21%
9
29
925
9282
9
6
926
9315
—
—
—
—
5
17
786
7933
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
3.3e-01
3.1e-01
1.2e+00
—
2.7e+00
4.6e-01
3.8e-01
cases:5.78%
controls:4.21%
cases:2.67%
controls:1.98%
cases:0.96%
controls:0.30%
—
—
cases:3.14%
controls:0.22%
cases:2.57%
controls:1.63%
cases:6.70%
controls:4.69%
54
392
880
8919
25
185
910
9136
9
28
926
9293
—
29
20
896
9282
23
148
873
8933
53
373
738
7577
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
4.1e-03
1.4e-01
1.3e+00
—
2.7e+00
5.3e-02
3.4e-01
cases:4.60%
controls:4.59%
cases:1.82%
controls:1.58%
cases:0.53%
controls:0.14%
—
—
cases:1.73%
controls:0.12%
cases:1.45%
controls:1.38%
cases:7.21%
controls:5.22%
43
427
891
8884
17
147
918
9174
5
13
930
9308
—
16
11
909
9291
13
125
883
8956
57
415
734
7535
Knee X-ray examination without contrast
NG1AA [2001308049]
NG1AA [2001308049]
1.1e+00
—
—
—
—
1.6e+00
7.7e-01
cases:3.00%
controls:1.03%
—
—
—
—
—
—
—
—
cases:1.34%
controls:0.28%
cases:2.40%
controls:1.13%
28
96
906
9215
—
—
—
—
12
25
884
9056
19
90
772
7860
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
6.1e-01
8.7e-01
1.5e+00
—
1.8e+00
8.9e-01
6.2e-01
cases:2.46%
controls:1.35%
cases:1.82%
controls:0.77%
cases:0.64%
controls:0.14%
—
—
cases:0.76%
controls:0.13%
cases:2.12%
controls:0.88%
cases:3.79%
controls:2.08%
23
126
911
9185
17
72
918
9249
6
13
929
9308
—
7
12
918
9290
19
80
877
9001
30
165
761
7785
No procedures
SPAT1301 [2001700402]
SPAT1301 [2001700402]
2.7e-01
5.3e-01
1.0e+00
—
1.8e+00
8.5e-01
1.1e-01
cases:6.42%
controls:4.98%
cases:2.78%
controls:1.66%
cases:0.96%
controls:0.35%
—
—
cases:1.62%
controls:0.27%
cases:4.02%
controls:1.76%
cases:6.19%
controls:5.58%
60
464
874
8847
26
155
909
9166
9
33
926
9288
—
15
25
910
9277
36
160
860
8921
49
444
742
7506
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
2.1e-01
—
—
1.0e+50
2.7e+00
—
5.2e-01
cases:1.61%
controls:1.31%
—
—
—
—
cases:1.39%
controls:0.00%
cases:0.76%
controls:0.05%
—
—
cases:1.64%
controls:0.98%
15
122
919
9189
—
—
13
0
922
9321
7
5
918
9297
—
13
78
778
7872
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
12286-1 [3011288]
7.5e-01
9.8e-01
—
—
—
1.6e+00
1.1e+00
cases:1.18%
controls:0.56%
cases:0.86%
controls:0.32%
—
—
—
—
—
—
cases:1.00%
controls:0.21%
cases:2.53%
controls:0.89%
11
52
923
9259
8
30
927
9291
—
—
—
9
19
887
9062
20
71
771
7879
clozapine; oral, parenteral
N05AH02 [21604542]
N05AH02 [21604542]
1.3e+00
1.2e+00
8.8e-01
—
7.4e-01
1.1e+00
1.3e+00
cases:1.28%
controls:0.34%
cases:1.07%
controls:0.33%
cases:0.64%
controls:0.27%
—
—
cases:0.65%
controls:0.31%
cases:1.00%
controls:0.35%
cases:1.52%
controls:0.43%
12
32
922
9279
10
31
925
9290
6
25
929
9296
—
6
29
919
9273
9
32
887
9049
12
34
779
7916
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
3.2e-01
2.7e-01
8.0e-01
—
1.6e+00
6.1e-01
4.1e-01
cases:8.46%
controls:6.29%
cases:4.39%
controls:3.39%
cases:1.50%
controls:0.68%
—
—
cases:2.59%
controls:0.55%
cases:6.03%
controls:3.36%
cases:13.15%
controls:9.11%
79
586
855
8725
41
316
894
9005
14
63
921
9258
—
24
51
901
9251
54
305
842
8776
104
724
687
7226
Shoulder X-ray examination without contrast
NB1AA [2001307225]
NB1AA [2001307225]
1.2e+00
-1.0e+50
—
—
—
1.4e+00
1.4e+00
cases:1.50%
controls:0.47%
cases:0.00%
controls:0.15%
—
—
—
—
—
—
cases:0.56%
controls:0.14%
cases:2.28%
controls:0.58%
14
44
920
9267
0
14
935
9307
—
—
—
5
13
891
9068
18
46
773
7904
Ocular pain
H57.1 [45596140]
H57.1 [45596140]
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.06%
—
—
—
—
—
—
—
6
5
890
9076
—
C peptide [Moles/volume] in Serum or Plasma --post meal
55919-5 [40759040]
55919-5 [40759040]
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.06%
—
—
—
—
—
—
—
6
5
890
9076
—
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
3.8e-01
4.4e-01
7.4e-01
—
2.6e-01
5.3e-01
4.1e-01
cases:18.74%
controls:13.60%
cases:11.02%
controls:7.39%
cases:3.64%
controls:1.77%
—
—
cases:2.16%
controls:1.68%
cases:12.39%
controls:7.66%
cases:22.25%
controls:16.03%
175
1266
759
8045
103
689
832
8632
34
165
901
9156
—
20
156
905
9146
111
696
785
8385
176
1274
615
6676
Anion gap in Serum or Plasma by calculation
33037-3 [3045716]
33037-3 [3045716]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.06%
—
—
—
—
—
—
6
5
785
7945
Fungus identified in Specimen by Culture
580-1 [3000494]
580-1 [3000494]
6.1e-01
—
—
—
2.5e+00
6.6e-01
1.0e-01
cases:2.57%
controls:1.42%
—
—
—
—
—
—
cases:0.65%
controls:0.05%
cases:0.89%
controls:0.46%
cases:2.28%
controls:2.06%
24
132
910
9179
—
—
—
6
5
919
9297
8
42
888
9039
18
164
773
7786
Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
41602-4 [3033386]
41602-4 [3033386]
2.5e+00
—
—
—
—
—
—
cases:0.64%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
928
9306
—
—
—
—
—
—
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
1.4e-01
1.9e-01
6.3e-01
2.5e+00
7.2e-01
3.0e-01
2.4e-01
cases:23.34%
controls:21.01%
cases:10.80%
controls:9.07%
cases:2.67%
controls:1.45%
cases:0.64%
controls:0.05%
cases:2.81%
controls:1.39%
cases:11.05%
controls:8.41%
cases:23.26%
controls:19.30%
218
1956
716
7355
101
845
834
8476
25
135
910
9186
6
5
929
9316
26
129
899
9173
99
764
797
8317
184
1534
607
6416
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
2.6e-01
8.9e-01
2.5e+00
1.0e+50
—
9.6e-01
3.3e-01
cases:3.32%
controls:2.58%
cases:1.60%
controls:0.67%
cases:0.64%
controls:0.05%
cases:1.60%
controls:0.00%
—
—
cases:1.56%
controls:0.61%
cases:3.16%
controls:2.29%
31
240
903
9071
15
62
920
9259
6
5
929
9316
15
0
920
9321
—
14
55
882
9026
25
182
766
7768
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
19550-3 [3028707]
1.2e+00
1.2e+00
—
—
—
1.5e+00
1.3e+00
cases:1.39%
controls:0.42%
cases:0.64%
controls:0.19%
—
—
—
—
—
—
cases:0.67%
controls:0.15%
cases:1.64%
controls:0.47%
13
39
921
9272
6
18
929
9303
—
—
—
6
14
890
9067
13
37
778
7913
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
X44 [45756400]
X44 [45756400]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.08%
—
—
—
—
—
—
7
6
784
7944
Contact with other hot fluids
X12 [45756371]
X12 [45756371]
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
2.5e+00
—
—
—
—
cases:1.07%
controls:0.00%
cases:22.14%
controls:0.00%
cases:10.49%
controls:0.00%
cases:3.35%
controls:0.00%
cases:0.88%
controls:0.08%
—
—
10
0
925
9321
207
0
728
9321
97
0
828
9302
30
0
866
9081
7
6
784
7944
Other bursitis of hip
M70.7 [45606305]
M70.7 [45606305]
2.5e+00
—
—
—
—
—
—
cases:0.75%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
7
6
927
9305
—
—
—
—
—
—
Emotionally unstable personality disorder
F60.3 [45566852]
F60.3 [45566852]
—
—
—
—
—
-1.0e+50
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
cases:1.01%
controls:0.09%
—
—
—
—
—
0
7
896
9074
8
7
783
7943
Anxiety disorder, unspecified
F41.9 [45542849]
F41.9 [45542849]
7.5e-01
1.2e+00
—
—
—
1.3e+00
5.3e-01
cases:2.36%
controls:1.13%
cases:1.50%
controls:0.47%
—
—
—
—
—
—
cases:1.79%
controls:0.52%
cases:3.03%
controls:1.81%
22
105
912
9206
14
44
921
9277
—
—
—
16
47
880
9034
24
144
767
7806
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
1.1e+00
6.9e-01
—
—
—
9.1e-01
1.3e+00
cases:1.71%
controls:0.60%
cases:0.86%
controls:0.43%
—
—
—
—
—
—
cases:1.12%
controls:0.45%
cases:2.28%
controls:0.64%
16
56
918
9255
8
40
927
9281
—
—
—
10
41
886
9040
18
51
773
7899
Difficulties in perfomrming procedure
ZXD30 [2001311389]
ZXD30 [2001311389]
4.4e-01
—
—
1.0e+50
—
2.3e+00
-1.0e+50
cases:0.75%
controls:0.48%
—
—
—
—
cases:0.86%
controls:0.00%
—
—
cases:0.78%
controls:0.08%
cases:0.00%
controls:0.29%
7
45
927
9266
—
—
8
0
927
9321
—
7
7
889
9074
0
23
791
7927
Cellulitis of other parts of limb
L03.1 [45586760]
L03.1 [45586760]
1.2e+00
—
—
—
—
2.3e+00
—
cases:0.64%
controls:0.20%
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.07%
—
—
6
19
928
9292
—
—
—
—
6
6
890
9075
—
Other leisure activity accident
Y94.8 [2000503731]
Y94.8 [2000503731]
—
—
—
1.0e+50
1.0e+50
2.3e+00
1.3e+00
—
—
—
—
—
—
cases:0.53%
controls:0.00%
cases:0.54%
controls:0.00%
cases:0.56%
controls:0.06%
cases:0.63%
controls:0.18%
—
—
—
5
0
930
9321
5
0
920
9302
5
5
891
9076
5
14
786
7936
Consultation of another employee
SPAT1260 [2001700361]
SPAT1260 [2001700361]
5.0e-01
6.5e-01
—
—
2.3e+00
9.3e-01
3.7e-01
cases:3.21%
controls:1.97%
cases:1.28%
controls:0.68%
—
—
—
—
cases:0.86%
controls:0.09%
cases:1.79%
controls:0.72%
cases:3.67%
controls:2.55%
30
183
904
9128
12
63
923
9258
—
—
8
8
917
9294
16
65
880
9016
29
203
762
7747
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
3.9e-01
4.7e-01
—
—
2.3e+00
8.8e-01
4.6e-01
cases:3.75%
controls:2.58%
cases:1.28%
controls:0.80%
—
—
—
—
cases:0.76%
controls:0.08%
cases:1.90%
controls:0.79%
cases:3.79%
controls:2.43%
35
240
899
9071
12
75
923
9246
—
—
7
7
918
9295
17
72
879
9009
30
193
761
7757
Post-traumatic wound infection, not elsewhere classified
T79.3 [45537002]
T79.3 [45537002]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.08%
—
—
—
—
—
—
6
6
785
7944
sulfadiazine and trimethoprim
J01EE02 [21602962]
J01EE02 [21602962]
4.6e-01
3.4e-01
-1.0e+50
—
2.3e+00
7.2e-01
4.0e-01
cases:5.46%
controls:3.51%
cases:1.18%
controls:0.84%
cases:0.00%
controls:0.14%
—
—
cases:0.65%
controls:0.06%
cases:1.67%
controls:0.83%
cases:3.41%
controls:2.31%
51
327
883
8984
11
78
924
9243
0
13
935
9308
—
6
6
919
9296
15
75
881
9006
27
184
764
7766
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
7.5e-01
6.3e-01
—
—
2.3e+00
9.4e-01
5.8e-01
cases:2.03%
controls:0.97%
cases:0.96%
controls:0.51%
—
—
—
—
cases:0.65%
controls:0.06%
cases:1.56%
controls:0.62%
cases:2.65%
controls:1.51%
19
90
915
9221
9
48
926
9273
—
—
6
6
919
9296
14
56
882
9025
21
120
770
7830
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
F19.1 [45552459]
F19.1 [45552459]
2.3e+00
—
—
—
—
—
2.0e+00
cases:0.64%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.09%
6
6
928
9305
—
—
—
—
—
5
7
786
7943
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
3.2e-01
1.3e+00
—
—
—
1.2e+00
1.0e+00
cases:0.96%
controls:0.70%
cases:1.18%
controls:0.32%
—
—
—
—
—
—
cases:1.00%
controls:0.30%
cases:2.02%
controls:0.75%
9
65
925
9246
11
30
924
9291
—
—
—
9
27
887
9054
16
60
775
7890
Neurology
13 [38004458]
13 [38004458]
5.5e-01
6.7e-01
8.8e-01
—
9.0e-01
6.1e-01
4.8e-01
cases:14.03%
controls:8.62%
cases:6.84%
controls:3.64%
cases:1.82%
controls:0.76%
—
—
cases:1.73%
controls:0.71%
cases:6.81%
controls:3.82%
cases:14.16%
controls:9.27%
131
803
803
8508
64
339
871
8982
17
71
918
9250
—
16
66
909
9236
61
347
835
8734
112
737
679
7213
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
Z76.9 [45609967]
9.1e-01
1.4e+00
—
—
—
7.4e-01
9.0e-01
cases:1.82%
controls:0.74%
cases:1.07%
controls:0.27%
—
—
—
—
—
—
cases:0.67%
controls:0.32%
cases:2.53%
controls:1.04%
17
69
917
9242
10
25
925
9296
—
—
—
6
29
890
9052
20
83
771
7867
risperidone; oral, parenteral
N05AX08 [21604559]
N05AX08 [21604559]
7.2e-01
8.2e-01
—
—
9.3e-01
1.1e+00
1.1e+00
cases:1.93%
controls:0.95%
cases:1.07%
controls:0.47%
—
—
—
—
cases:0.54%
controls:0.22%
cases:1.56%
controls:0.51%
cases:3.41%
controls:1.11%
18
88
916
9223
10
44
925
9277
—
—
5
20
920
9282
14
46
882
9035
27
88
764
7862
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
4.8e-01
6.0e-01
1.0e+00
—
9.3e-01
6.1e-01
5.7e-01
cases:9.85%
controls:6.34%
cases:4.49%
controls:2.51%
cases:0.75%
controls:0.27%
—
—
cases:0.97%
controls:0.39%
cases:4.13%
controls:2.28%
cases:11.50%
controls:6.86%
92
590
842
8721
42
234
893
9087
7
25
928
9296
—
9
36
916
9266
37
207
859
8874
91
545
700
7405
Treatment of reopened or infected surgical wound
SPAT1144 [2001700245]
SPAT1144 [2001700245]
8.5e-01
—
—
—
1.0e+50
2.2e+00
9.3e-01
cases:1.07%
controls:0.46%
—
—
—
—
—
—
cases:0.54%
controls:0.00%
cases:1.34%
controls:0.14%
cases:1.26%
controls:0.50%
10
43
924
9268
—
—
—
5
0
920
9302
12
13
884
9068
10
40
781
7910
Urinary tract ultrasound examination
KH1AE [2001306329]
KH1AE [2001306329]
8.1e-01
—
—
—
-1.0e+50
2.2e+00
8.4e-01
cases:0.96%
controls:0.43%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.89%
controls:0.10%
cases:1.39%
controls:0.60%
9
40
925
9271
—
—
—
0
6
925
9296
8
9
888
9072
11
48
780
7902
Fitting and adjustment of dental prosthetic device
Z46.3 [45537642]
Z46.3 [45537642]
—
—
—
—
—
-1.0e+50
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.01%
controls:0.11%
—
—
—
—
—
0
5
896
9076
8
9
783
7941
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
2.6e-01
3.9e-01
8.0e-01
—
1.3e+00
4.6e-01
4.8e-01
cases:20.56%
controls:16.66%
cases:8.98%
controls:6.29%
cases:1.60%
controls:0.73%
—
—
cases:2.38%
controls:0.69%
cases:9.60%
controls:6.30%
cases:28.57%
controls:19.81%
192
1551
742
7760
84
586
851
8735
15
68
920
9253
—
22
64
903
9238
86
572
810
8509
226
1575
565
6375
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
5.2e-01
8.5e-01
1.3e+00
—
2.2e+00
7.7e-01
1.7e-01
cases:1.93%
controls:1.16%
cases:1.50%
controls:0.64%
cases:0.75%
controls:0.21%
—
—
cases:2.27%
controls:0.26%
cases:1.79%
controls:0.84%
cases:2.28%
controls:1.92%
18
108
916
9203
14
60
921
9261
7
20
928
9301
—
21
24
904
9278
16
76
880
9005
18
153
773
7797
Fall on and from stairs and steps
W10 [45756250]
W10 [45756250]
8.2e-01
—
—
—
—
2.2e+00
4.6e-01
cases:1.07%
controls:0.47%
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.09%
cases:0.76%
controls:0.48%
10
44
924
9267
—
—
—
—
7
8
889
9073
6
38
785
7912
Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11259-9 [3021125]
11259-9 [3021125]
1.3e+00
—
—
—
—
—
2.2e+00
cases:0.54%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.10%
5
13
929
9298
—
—
—
—
—
7
8
784
7942
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
F32.10 [2000501980]
1.0e+00
6.1e-01
—
—
—
6.7e-01
1.1e+00
cases:2.46%
controls:0.89%
cases:0.75%
controls:0.41%
—
—
—
—
—
—
cases:0.56%
controls:0.29%
cases:2.78%
controls:0.91%
23
83
911
9228
7
38
928
9283
—
—
—
5
26
891
9055
22
72
769
7878
Disorientation, unspecified
R41.0 [45558469]
R41.0 [45558469]
2.2e+00
—
—
—
—
-1.0e+50
—
cases:0.75%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
7
8
927
9303
—
—
—
—
0
6
896
9075
—
Constipation, unspecified
K59.09 [2000502926]
K59.09 [2000502926]
5.8e-01
—
—
—
—
2.2e+00
4.8e-01
cases:0.86%
controls:0.48%
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.08%
cases:1.01%
controls:0.63%
8
45
926
9266
—
—
—
—
6
7
890
9074
8
50
783
7900
Bipolar affective disorder, current episode hypomanic
F31.0 [45542840]
F31.0 [45542840]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.09%
—
—
—
—
—
—
6
7
785
7943
Acute alcohol abuse
P16 [2002000812]
P16 [2002000812]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.15%
—
—
—
—
—
—
10
12
781
7938
Urine methamphetamine measurement
313579004 [4198724]
313579004 [4198724]
2.1e+00
—
—
—
—
—
1.9e+00
cases:1.07%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.11%
10
12
924
9299
—
—
—
—
—
6
9
785
7941
Other specified local infections of skin and subcutaneous tissue
L08.8 [45601211]
L08.8 [45601211]
1.3e+00
-1.0e+50
—
—
—
—
2.1e+00
cases:0.64%
controls:0.18%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.14%
controls:0.14%
6
17
928
9294
0
6
935
9315
—
—
—
—
9
11
782
7939
Very extensive MRI examination of brain with high intensity magnet
AA1DG [2001300120]
AA1DG [2001300120]
-1.0e+50
—
—
—
—
—
2.1e+00
cases:0.00%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.13%
0
20
934
9291
—
—
—
—
—
8
10
783
7940
Major dressing of wound of skin of trunk
QBB10 [2001309842]
QBB10 [2001309842]
6.2e-01
2.1e+00
—
—
1.0e+50
—
1.3e+00
cases:0.54%
controls:0.29%
cases:0.86%
controls:0.11%
—
—
—
—
cases:0.97%
controls:0.00%
—
—
cases:1.01%
controls:0.26%
5
27
929
9284
8
10
927
9311
—
—
9
0
916
9302
—
8
21
783
7929
Limited function/disability (N)
N28 [2002000733]
N28 [2002000733]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.11%
—
—
—
—
—
—
7
9
784
7941
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
2.9e-01
-6.9e-02
1.2e+00
—
2.1e+00
3.1e-01
4.3e-01
cases:4.18%
controls:3.15%
cases:1.28%
controls:1.37%
cases:0.64%
controls:0.20%
—
—
cases:0.76%
controls:0.10%
cases:1.56%
controls:1.15%
cases:4.93%
controls:3.26%
39
293
895
9018
12
128
923
9193
6
19
929
9302
—
7
9
918
9293
14
104
882
8977
39
259
752
7691
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
2.5e-01
2.5e-01
5.1e-01
—
1.2e+00
4.3e-01
3.9e-01
cases:14.35%
controls:11.59%
cases:8.02%
controls:6.34%
cases:1.60%
controls:0.97%
—
—
cases:2.81%
controls:0.84%
cases:9.60%
controls:6.48%
cases:22.50%
controls:16.44%
134
1079
800
8232
75
591
860
8730
15
90
920
9231
—
26
78
899
9224
86
588
810
8493
178
1307
613
6643
naltrexone; oral
N07BB04 [21604824]
N07BB04 [21604824]
2.0e+00
—
—
—
—
—
—
cases:1.07%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
10
13
924
9298
—
—
—
—
—
—
Medical abortion, complete or unspecified, without complication
O04.9 [45543909]
O04.9 [45543909]
1.9e-01
—
—
—
—
2.0e+00
5.8e-01
cases:0.75%
controls:0.62%
—
—
—
—
—
—
—
—
cases:1.00%
controls:0.13%
cases:1.14%
controls:0.64%
7
58
927
9253
—
—
—
—
9
12
887
9069
9
51
782
7899
Procedure not carried out because of patient's decision for other and unspecified reasons
Z53.2 [45605136]
Z53.2 [45605136]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.10%
—
—
—
—
—
—
6
8
785
7942
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
2.6e-01
3.0e-01
-1.0e+50
—
2.0e+00
-2.5e-01
2.4e-01
cases:2.68%
controls:2.08%
cases:1.07%
controls:0.79%
cases:0.00%
controls:0.14%
—
—
cases:0.65%
controls:0.09%
cases:0.56%
controls:0.72%
cases:3.16%
controls:2.50%
25
194
909
9117
10
74
925
9247
0
13
935
9308
—
6
8
919
9294
5
65
891
9016
25
199
766
7751
Bacteria identified in Cerebral spinal fluid by Culture
606-4 [3016914]
606-4 [3016914]
2.0e+00
—
—
—
—
—
—
cases:0.64%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
928
9303
—
—
—
—
—
—
Car occupant [any] injured in unspecified traffic accident
V49.9 [45566025]
V49.9 [45566025]
1.3e+00
1.6e+00
—
—
—
2.0e+00
1.3e+00
cases:0.96%
controls:0.27%
cases:0.64%
controls:0.13%
—
—
—
—
—
—
cases:0.89%
controls:0.12%
cases:1.26%
controls:0.36%
9
25
925
9286
6
12
929
9309
—
—
—
8
11
888
9070
10
29
781
7921
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
6.1e-01
8.3e-01
1.1e+00
—
6.1e-01
5.8e-01
5.5e-01
cases:6.85%
controls:3.84%
cases:4.06%
controls:1.81%
cases:1.18%
controls:0.41%
—
—
cases:0.65%
controls:0.35%
cases:3.24%
controls:1.84%
cases:6.57%
controls:3.89%
64
358
870
8953
38
169
897
9152
11
38
924
9283
—
6
33
919
9269
29
167
867
8914
52
309
739
7641
Atrioventricular block, complete
I44.2 [45576872]
I44.2 [45576872]
1.4e+00
—
—
—
—
2.0e+00
4.9e-01
cases:0.75%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.11%
cases:0.63%
controls:0.39%
7
17
927
9294
—
—
—
—
7
10
889
9071
5
31
786
7919
Patella X-ray examination
NG2AA [2001308078]
NG2AA [2001308078]
—
—
—
—
—
-1.0e+50
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.07%
cases:0.88%
controls:0.13%
—
—
—
—
—
0
6
896
9075
7
10
784
7940
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
1.3e+00
1.1e+00
—
—
—
—
1.9e+00
cases:0.86%
controls:0.24%
cases:0.53%
controls:0.18%
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.20%
8
22
926
9289
5
17
930
9304
—
—
—
—
11
16
780
7934
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
3.3e-01
4.3e-01
—
—
1.9e+00
4.7e-01
3.7e-01
cases:5.25%
controls:3.82%
cases:3.10%
controls:2.05%
—
—
—
—
cases:1.30%
controls:0.19%
cases:3.13%
controls:1.97%
cases:8.72%
controls:6.16%
49
356
885
8955
29
191
906
9130
—
—
12
18
913
9284
28
179
868
8902
69
490
722
7460
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
1.4e-01
-1.2e-01
1.1e+00
—
1.9e+00
4.8e-01
4.7e-01
cases:3.64%
controls:3.19%
cases:1.28%
controls:1.45%
cases:0.53%
controls:0.17%
—
—
cases:0.86%
controls:0.13%
cases:1.90%
controls:1.18%
cases:5.69%
controls:3.62%
34
297
900
9014
12
135
923
9186
5
16
930
9305
—
8
12
917
9290
17
107
879
8974
45
288
746
7662
Suture or treatment of traumatic wound
SPAT1149 [2001700250]
SPAT1149 [2001700250]
4.3e-01
—
—
—
—
1.9e+00
7.7e-01
cases:1.82%
controls:1.19%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.29%
cases:2.91%
controls:1.37%
17
111
917
9200
—
—
—
—
17
26
879
9055
23
109
768
7841
magnesium hydroxide; oral
G04BX01 [21602658]
G04BX01 [21602658]
—
1.9e+00
—
—
—
1.4e+00
2.8e-01
—
—
cases:0.86%
controls:0.13%
—
—
—
—
—
—
cases:0.56%
controls:0.13%
cases:0.63%
controls:0.48%
—
8
12
927
9309
—
—
—
5
12
891
9069
5
38
786
7912
magnesium hydroxide; oral
A02AA04 [21600052]
A02AA04 [21600052]
—
1.9e+00
—
—
—
1.4e+00
2.8e-01
—
—
cases:0.86%
controls:0.13%
—
—
—
—
—
—
cases:0.56%
controls:0.13%
cases:0.63%
controls:0.48%
—
8
12
927
9309
—
—
—
5
12
891
9069
5
38
786
7912
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
1.9e-01
5.1e-01
2.5e-01
—
1.3e+00
6.0e-01
3.8e-01
cases:7.71%
controls:6.48%
cases:4.28%
controls:2.62%
cases:0.53%
controls:0.42%
—
—
cases:1.41%
controls:0.39%
cases:4.69%
controls:2.63%
cases:9.99%
controls:7.06%
72
603
862
8708
40
244
895
9077
5
39
930
9282
—
13
36
912
9266
42
239
854
8842
79
561
712
7389
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
F33.11 [2000501985]
—
-1.0e+50
—
—
—
-1.0e+50
1.9e+00
—
—
cases:0.00%
controls:0.05%
—
—
—
—
—
—
cases:0.00%
controls:0.07%
cases:0.88%
controls:0.14%
—
0
5
935
9316
—
—
—
0
6
896
9075
7
11
784
7939
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
4.9e-01
3.2e-01
1.2e+00
1.0e+50
1.9e+00
4.3e-01
6.9e-02
cases:4.28%
controls:2.67%
cases:1.93%
controls:1.41%
cases:0.64%
controls:0.19%
cases:0.64%
controls:0.00%
cases:0.76%
controls:0.12%
cases:2.01%
controls:1.31%
cases:4.05%
controls:3.79%
40
249
894
9062
18
131
917
9190
6
18
929
9303
6
0
929
9321
7
11
918
9291
18
119
878
8962
32
301
759
7649
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
5.8e-01
7.9e-01
1.9e+00
1.0e+50
—
1.5e-01
-2.8e-02
cases:2.03%
controls:1.15%
cases:1.71%
controls:0.78%
cases:0.75%
controls:0.12%
cases:0.75%
controls:0.00%
—
—
cases:1.00%
controls:0.87%
cases:1.14%
controls:1.17%
19
107
915
9204
16
73
919
9248
7
11
928
9310
7
0
928
9321
—
9
79
887
9002
9
93
782
7857
chlordiazepoxide; oral, parenteral
N05BA02 [21604567]
N05BA02 [21604567]
1.9e+00
1.8e+00
—
—
—
—
—
cases:1.28%
controls:0.20%
cases:0.53%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
12
19
922
9292
5
8
930
9313
—
—
—
—
—
Prostate Pathology biopsy report
66117-3 [40768800]
66117-3 [40768800]
—
-1.0e+50
—
—
—
—
1.8e+00
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
—
—
cases:1.01%
controls:0.16%
—
0
12
935
9309
—
—
—
—
8
13
783
7937
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
7974-9 [3008909]
1.8e+00
—
—
—
—
—
7.3e-01
cases:0.86%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.43%
8
13
926
9298
—
—
—
—
—
7
34
784
7916
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
7.9e-01
1.6e-01
—
—
—
4.2e-01
1.0e+00
cases:3.10%
controls:1.43%
cases:0.64%
controls:0.55%
—
—
—
—
—
—
cases:0.67%
controls:0.44%
cases:2.65%
controls:0.97%
29
133
905
9178
6
51
929
9270
—
—
—
6
40
890
9041
21
77
770
7873
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
7.9e-01
1.6e-01
—
—
—
4.2e-01
1.0e+00
cases:3.10%
controls:1.43%
cases:0.64%
controls:0.55%
—
—
—
—
—
—
cases:0.67%
controls:0.44%
cases:2.65%
controls:0.97%
29
133
905
9178
6
51
929
9270
—
—
—
6
40
890
9041
21
77
770
7873
FEV1
20150-9 [3024653]
20150-9 [3024653]
7.9e-01
1.6e-01
—
—
—
4.2e-01
1.0e+00
cases:3.10%
controls:1.43%
cases:0.64%
controls:0.55%
—
—
—
—
—
—
cases:0.67%
controls:0.44%
cases:2.65%
controls:0.97%
29
133
905
9178
6
51
929
9270
—
—
—
6
40
890
9041
21
77
770
7873
clidinium and psycholeptics
A03CA02 [21600204]
A03CA02 [21600204]
3.7e-01
1.3e+00
—
—
—
1.8e+00
9.1e-01
cases:1.07%
controls:0.74%
cases:0.96%
controls:0.27%
—
—
—
—
—
—
cases:1.00%
controls:0.17%
cases:1.52%
controls:0.62%
10
69
924
9242
9
25
926
9296
—
—
—
9
15
887
9066
12
49
779
7901
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
8.0e-01
4.8e-01
—
—
—
5.6e-01
1.0e+00
cases:2.46%
controls:1.12%
cases:1.07%
controls:0.67%
—
—
—
—
—
—
cases:1.23%
controls:0.70%
cases:4.30%
controls:1.62%
23
104
911
9207
10
62
925
9259
—
—
—
11
64
885
9017
34
129
757
7821
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
14731-4 [3019309]
1.9e-01
3.8e-01
-1.0e+50
—
—
1.0e+00
7.5e-01
cases:3.32%
controls:2.75%
cases:1.28%
controls:0.88%
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.79%
controls:0.64%
cases:5.06%
controls:2.45%
31
256
903
9055
12
82
923
9239
0
10
935
9311
—
—
16
58
880
9023
40
195
751
7755
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
1.5e-01
3.4e-01
2.5e-01
—
1.3e+00
4.0e-01
4.9e-01
cases:6.42%
controls:5.60%
cases:3.53%
controls:2.53%
cases:0.53%
controls:0.42%
—
—
cases:1.41%
controls:0.39%
cases:3.57%
controls:2.41%
cases:12.39%
controls:8.00%
60
521
874
8790
33
236
902
9085
5
39
930
9282
—
13
36
912
9266
32
219
864
8862
98
636
693
7314
Leg/thigh symptom/complaint
L14 [2002000638]
L14 [2002000638]
-2.3e-02
—
—
—
—
1.8e+00
-9.1e-02
cases:0.54%
controls:0.55%
—
—
—
—
—
—
—
—
cases:0.78%
controls:0.13%
cases:0.76%
controls:0.83%
5
51
929
9260
—
—
—
—
7
12
889
9069
6
66
785
7884
Other physical therapy
Z50.1 [45600331]
Z50.1 [45600331]
6.1e-01
-1.0e+50
—
—
—
1.8e+00
—
cases:0.75%
controls:0.41%
cases:0.00%
controls:0.12%
—
—
—
—
—
—
cases:0.78%
controls:0.13%
—
—
7
38
927
9273
0
11
935
9310
—
—
—
7
12
889
9069
—
Mucosa-supported partial denture
SPE01 [2001310537]
SPE01 [2001310537]
-1.0e+50
—
—
—
—
-1.0e+50
1.8e+00
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.88%
controls:0.15%
0
8
934
9303
—
—
—
—
0
5
896
9076
7
12
784
7938
General symptom/complaint other
A29 [2002000163]
A29 [2002000163]
-3.6e-01
-8.1e-02
-1.0e+50
—
—
1.0e+00
7.4e-01
cases:0.86%
controls:1.22%
cases:0.53%
controls:0.58%
cases:0.00%
controls:0.12%
—
—
—
—
cases:1.56%
controls:0.56%
cases:3.79%
controls:1.85%
8
114
926
9197
5
54
930
9267
0
11
935
9310
—
—
14
51
882
9030
30
147
761
7803
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
4.6e-01
7.4e-01
1.3e+00
—
—
1.0e+00
7.6e-01
cases:2.03%
controls:1.29%
cases:1.39%
controls:0.67%
cases:0.75%
controls:0.21%
—
—
—
—
cases:2.12%
controls:0.78%
cases:4.68%
controls:2.25%
19
120
915
9191
13
62
922
9259
7
20
928
9301
—
—
19
71
877
9010
37
179
754
7771
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
F20.30 [2000501944]
1.8e+00
—
—
—
—
—
1.5e+00
cases:0.75%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.16%
7
12
927
9299
—
—
—
—
—
6
13
785
7937
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
L97 [45591659]
7.3e-01
—
—
—
—
1.8e+00
1.2e+00
cases:0.54%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.15%
cases:1.01%
controls:0.30%
5
24
929
9287
—
—
—
—
8
14
888
9067
8
24
783
7926
Nursing episode
950 [44777714]
950 [44777714]
3.5e-01
2.0e-01
1.2e+00
—
1.8e+00
3.9e-01
4.5e-01
cases:1.28%
controls:0.91%
cases:0.75%
controls:0.61%
cases:0.64%
controls:0.20%
—
—
cases:1.30%
controls:0.23%
cases:0.89%
controls:0.61%
cases:2.53%
controls:1.62%
12
85
922
9226
7
57
928
9264
6
19
929
9302
—
12
21
913
9281
8
55
888
9026
20
129
771
7821
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
F60.31 [2000502023]
1.7e+00
—
—
—
—
—
1.4e+00
cases:0.86%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.19%
8
14
926
9297
—
—
—
—
—
6
15
785
7935
Occupatioal Medicine
901 [44777713]
901 [44777713]
1.7e+00
—
—
—
—
—
1.4e+00
cases:0.86%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.23%
8
14
926
9297
—
—
—
—
—
7
18
784
7932
flucloxacillin; oral, parenteral
J01CF05 [21602857]
J01CF05 [21602857]
5.9e-01
1.1e+00
—
—
—
1.7e+00
7.8e-01
cases:0.75%
controls:0.42%
cases:0.53%
controls:0.17%
—
—
—
—
—
—
cases:1.12%
controls:0.20%
cases:1.90%
controls:0.88%
7
39
927
9272
5
16
930
9305
—
—
—
10
18
886
9063
15
70
776
7880
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
4.3e-01
3.4e-01
1.7e+00
—
1.3e+00
4.6e-01
4.5e-01
cases:2.89%
controls:1.90%
cases:1.60%
controls:1.15%
cases:1.50%
controls:0.27%
—
—
cases:0.86%
controls:0.24%
cases:1.67%
controls:1.07%
cases:4.30%
controls:2.79%
27
177
907
9134
15
107
920
9214
14
25
921
9296
—
8
22
917
9280
15
97
881
8984
34
222
757
7728
Constipation
D12 [2002000311]
D12 [2002000311]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.25%
—
—
—
—
—
—
11
20
780
7930
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
21573-1 [3003031]
5.9e-01
8.1e-01
—
—
—
9.6e-01
7.5e-01
cases:4.07%
controls:2.30%
cases:1.82%
controls:0.82%
—
—
—
—
—
—
cases:1.90%
controls:0.74%
cases:6.07%
controls:2.97%
38
214
896
9097
17
76
918
9245
—
—
—
17
67
879
9014
48
236
743
7714
Remowal of suture of skin
TQW40 [2001310146]
TQW40 [2001310146]
9.8e-01
—
—
—
—
1.7e+00
1.7e+00
cases:1.39%
controls:0.53%
—
—
—
—
—
—
—
—
cases:0.67%
controls:0.12%
cases:1.90%
controls:0.35%
13
49
921
9262
—
—
—
—
6
11
890
9070
15
28
776
7922
nitrofurantoin; oral
J01XE01 [21603058]
J01XE01 [21603058]
2.3e-01
6.8e-01
—
—
—
1.0e+00
6.9e-01
cases:2.14%
controls:1.71%
cases:1.50%
controls:0.76%
—
—
—
—
—
—
cases:1.79%
controls:0.66%
cases:4.30%
controls:2.20%
20
159
914
9152
14
71
921
9250
—
—
—
16
60
880
9021
34
175
757
7775
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
8.9e-01
1.0e+00
—
—
1.5e+00
6.8e-01
8.0e-01
cases:3.64%
controls:1.53%
cases:1.50%
controls:0.55%
—
—
—
—
cases:0.54%
controls:0.12%
cases:1.23%
controls:0.63%
cases:4.30%
controls:1.97%
34
142
900
9169
14
51
921
9270
—
—
5
11
920
9291
11
57
885
9024
34
157
757
7793
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
4.5e-01
4.5e-01
—
—
1.7e+00
6.8e-01
4.7e-01
cases:2.14%
controls:1.37%
cases:1.39%
controls:0.89%
—
—
—
—
cases:0.86%
controls:0.16%
cases:1.67%
controls:0.86%
cases:4.42%
controls:2.82%
20
128
914
9183
13
83
922
9238
—
—
8
15
917
9287
15
78
881
9003
35
224
756
7726
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
3.3e-01
2.2e-02
3.1e-01
—
1.0e+00
3.9e-01
3.2e-01
cases:16.60%
controls:12.49%
cases:6.95%
controls:6.81%
cases:1.39%
controls:1.02%
—
—
cases:2.16%
controls:0.78%
cases:9.49%
controls:6.61%
cases:23.39%
controls:18.09%
155
1163
779
8148
65
635
870
8686
13
95
922
9226
—
20
73
905
9229
85
600
811
8481
185
1438
606
6512
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
5.0e-01
—
-1.0e+50
1.0e+50
—
1.7e+00
2.7e-01
cases:1.50%
controls:0.91%
—
—
cases:0.00%
controls:0.05%
cases:0.53%
controls:0.00%
—
—
cases:1.12%
controls:0.21%
cases:1.39%
controls:1.07%
14
85
920
9226
—
0
5
935
9316
5
0
930
9321
—
10
19
886
9062
11
85
780
7865
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
2518-9 [3018405]
9.8e-01
1.7e+00
—
—
—
—
4.5e-01
cases:0.96%
controls:0.37%
cases:0.86%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.40%
9
34
925
9277
8
15
927
9306
—
—
—
—
5
32
786
7918
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
2.4e-01
-1.0e-01
—
—
1.7e+00
3.9e-01
3.5e-01
cases:5.03%
controls:4.02%
cases:2.03%
controls:2.24%
—
—
—
—
cases:1.30%
controls:0.25%
cases:2.90%
controls:1.98%
cases:7.46%
controls:5.36%
47
374
887
8937
19
209
916
9112
—
—
12
23
913
9279
26
180
870
8901
59
426
732
7524
solifenacin; oral
G04BD08 [21602641]
G04BD08 [21602641]
1.1e+00
1.2e+00
—
—
—
1.6e+00
1.3e+00
cases:1.28%
controls:0.45%
cases:0.86%
controls:0.25%
—
—
—
—
—
—
cases:1.00%
controls:0.20%
cases:1.26%
controls:0.35%
12
42
922
9269
8
23
927
9298
—
—
—
9
18
887
9063
10
28
781
7922
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
2.9e-01
3.4e-02
5.4e-01
—
1.6e+00
4.4e-01
3.8e-01
cases:6.21%
controls:4.70%
cases:2.67%
controls:2.59%
cases:0.64%
controls:0.38%
—
—
cases:1.51%
controls:0.30%
cases:3.68%
controls:2.40%
cases:9.61%
controls:6.79%
58
438
876
8873
25
241
910
9080
6
35
929
9286
—
14
28
911
9274
33
218
863
8863
76
540
715
7410
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
2.4e-01
1.6e-02
—
—
1.6e+00
3.5e-01
3.9e-01
cases:5.14%
controls:4.09%
cases:2.35%
controls:2.32%
—
—
—
—
cases:1.30%
controls:0.26%
cases:2.90%
controls:2.07%
cases:8.09%
controls:5.61%
48
381
886
8930
22
216
913
9105
—
—
12
24
913
9278
26
188
870
8893
64
446
727
7504
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
1.5e-01
1.7e-01
6.3e-01
—
1.2e+00
4.3e-01
4.5e-01
cases:7.49%
controls:6.54%
cases:6.20%
controls:5.28%
cases:2.35%
controls:1.27%
—
—
cases:3.35%
controls:1.06%
cases:8.26%
controls:5.55%
cases:15.80%
controls:10.67%
70
609
864
8702
58
492
877
8829
22
118
913
9203
—
31
99
894
9203
74
504
822
8577
125
848
666
7102
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
7.7e-01
6.1e-01
1.0e+00
—
1.6e+00
1.2e-01
5.7e-02
cases:2.14%
controls:1.00%
cases:1.18%
controls:0.64%
cases:0.53%
controls:0.19%
—
—
cases:0.86%
controls:0.17%
cases:0.78%
controls:0.69%
cases:1.26%
controls:1.19%
20
93
914
9218
11
60
924
9261
5
18
930
9303
—
8
16
917
9286
7
63
889
9018
10
95
781
7855
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
1.9e-01
5.4e-01
1.6e+00
—
1.0e+00
5.9e-01
4.0e-01
cases:4.07%
controls:3.40%
cases:2.99%
controls:1.76%
cases:1.28%
controls:0.26%
—
—
cases:0.86%
controls:0.31%
cases:3.24%
controls:1.83%
cases:8.34%
controls:5.76%
38
317
896
8994
28
164
907
9157
12
24
923
9297
—
8
29
917
9273
29
166
867
8915
66
458
725
7492
Alcohol intoxication UNS
F10.09 [2000501676]
F10.09 [2000501676]
1.6e+00
—
—
—
—
—
—
cases:0.86%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
—
—
8
16
926
9295
—
—
—
—
—
—
Fall on same level involving ice and snow
W00 [45756242]
W00 [45756242]
5.4e-01
1.6e+00
—
—
—
—
7.1e-01
cases:1.39%
controls:0.82%
cases:0.86%
controls:0.17%
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.94%
13
76
921
9235
8
16
927
9305
—
—
—
—
15
75
776
7875
Nutritional therapy
R4190 [2001310243]
R4190 [2001310243]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.31%
—
—
—
—
—
—
12
25
779
7925
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
3.3e-01
—
—
—
—
1.6e+00
7.1e-01
cases:1.18%
controls:0.85%
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.23%
cases:1.52%
controls:0.75%
11
79
923
9232
—
—
—
—
10
21
886
9060
12
60
779
7890
Contusion of hip
S70.0 [45574306]
S70.0 [45574306]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.26%
—
—
—
—
—
—
10
21
781
7929
Oxygen saturation in Venous blood
2711-0 [3024928]
2711-0 [3024928]
1.6e+00
—
—
—
—
—
8.9e-01
cases:0.96%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.36%
9
19
925
9292
—
—
—
—
—
7
29
784
7921
Contusion of shoulder and upper arm
S40.0 [45563774]
S40.0 [45563774]
1.6e+00
—
—
—
—
—
—
cases:0.96%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
—
—
9
19
925
9292
—
—
—
—
—
—
orphenadrine, combinations
M03BC51 [21604113]
M03BC51 [21604113]
3.2e-01
5.4e-02
—
—
-1.0e+50
9.7e-01
5.8e-01
cases:4.50%
controls:3.30%
cases:1.18%
controls:1.12%
—
—
—
—
cases:0.00%
controls:0.12%
cases:1.79%
controls:0.68%
cases:5.18%
controls:2.96%
42
307
892
9004
11
104
924
9217
—
—
0
11
925
9291
16
62
880
9019
41
235
750
7715
Functional endoscopic opening of maxillary antrum
DMB20 [2001301780]
DMB20 [2001301780]
6.9e-01
-1.0e+50
—
—
—
—
1.5e+00
cases:0.54%
controls:0.27%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.33%
5
25
929
9286
0
6
935
9315
—
—
—
—
12
26
779
7924
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
5.5e-01
9.9e-01
—
—
1.0e+00
4.6e-01
4.2e-01
cases:6.96%
controls:4.12%
cases:4.71%
controls:1.80%
—
—
—
—
cases:0.65%
controls:0.24%
cases:2.90%
controls:1.85%
cases:9.10%
controls:6.18%
65
384
869
8927
44
168
891
9153
—
—
6
22
919
9280
26
168
870
8913
72
491
719
7459
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
3.1e-01
-6.9e-03
3.6e-01
—
1.5e+00
2.8e-01
2.7e-01
cases:6.75%
controls:5.05%
cases:2.99%
controls:3.01%
cases:0.64%
controls:0.45%
—
—
cases:1.84%
controls:0.41%
cases:4.02%
controls:3.06%
cases:10.62%
controls:8.30%
63
470
871
8841
28
281
907
9040
6
42
929
9279
—
17
38
908
9264
36
278
860
8803
84
660
707
7290
lithium; oral
N05AN01 [21604556]
N05AN01 [21604556]
1.1e+00
1.3e+00
—
—
-1.0e+50
1.5e+00
1.5e+00
cases:0.86%
controls:0.29%
cases:0.75%
controls:0.20%
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.89%
controls:0.21%
cases:1.14%
controls:0.25%
8
27
926
9284
7
19
928
9302
—
—
0
5
925
9297
8
19
888
9062
9
20
782
7930
Other chronic pain
R52.2 [45568139]
R52.2 [45568139]
1.5e+00
—
—
—
—
—
1.0e+00
cases:0.96%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.33%
9
20
925
9291
—
—
—
—
—
7
26
784
7924
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
2.1e-01
2.7e-01
5.9e-01
—
1.5e+00
4.3e-01
3.0e-01
cases:6.75%
controls:5.52%
cases:3.74%
controls:2.88%
cases:0.75%
controls:0.42%
—
—
cases:1.51%
controls:0.34%
cases:3.91%
controls:2.57%
cases:9.86%
controls:7.52%
63
514
871
8797
35
268
900
9053
7
39
928
9282
—
14
32
911
9270
35
233
861
8848
78
598
713
7352
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
2.6e-01
5.3e-01
7.3e-01
—
9.6e-01
3.1e-01
3.4e-01
cases:8.99%
controls:7.07%
cases:6.10%
controls:3.69%
cases:1.39%
controls:0.68%
—
—
cases:1.73%
controls:0.67%
cases:5.13%
controls:3.83%
cases:13.53%
controls:10.04%
84
658
850
8653
57
344
878
8977
13
63
922
9258
—
16
62
909
9240
46
348
850
8733
107
798
684
7152
Other fall from one level to another
W17 [45756255]
W17 [45756255]
2.5e-01
—
—
—
—
—
1.5e+00
cases:0.54%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:1.90%
controls:0.44%
5
39
929
9272
—
—
—
—
—
15
35
776
7915
Lumbar puncture
TAB00 [2001300538]
TAB00 [2001300538]
1.5e+00
—
—
—
—
—
8.8e-01
cases:1.39%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.26%
13
30
921
9281
—
—
—
—
—
5
21
786
7929
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 [3016921]
11090-8 [3016921]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.35%
—
—
—
—
—
—
12
28
779
7922
etoricoxib; oral
M01AH05 [21603996]
M01AH05 [21603996]
2.4e-01
4.6e-01
1.1e+00
—
4.5e-01
1.8e-01
3.5e-01
cases:14.56%
controls:11.78%
cases:6.84%
controls:4.43%
cases:1.82%
controls:0.60%
—
—
cases:0.97%
controls:0.62%
cases:5.25%
controls:4.40%
cases:18.20%
controls:13.56%
136
1097
798
8214
64
413
871
8908
17
56
918
9265
—
9
58
916
9244
47
400
849
8681
144
1078
647
6872
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
4.8e-01
6.5e-01
—
—
—
8.9e-01
5.8e-01
cases:4.93%
controls:3.09%
cases:2.14%
controls:1.13%
—
—
—
—
—
—
cases:2.46%
controls:1.02%
cases:6.32%
controls:3.65%
46
288
888
9023
20
105
915
9216
—
—
—
22
93
874
8988
50
290
741
7660
Gastroenterology
10 [38004455]
10 [38004455]
3.6e-01
5.7e-01
—
—
—
7.6e-01
6.9e-01
cases:5.78%
controls:4.11%
cases:3.32%
controls:1.91%
—
—
—
—
—
—
cases:3.68%
controls:1.75%
cases:9.61%
controls:5.06%
54
383
880
8928
31
178
904
9143
—
—
—
33
159
863
8922
76
402
715
7548
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
74661-0 [44816559]
5.1e-01
—
-1.0e+50
—
—
1.4e+00
8.8e-01
cases:0.54%
controls:0.32%
—
—
cases:0.00%
controls:0.05%
—
—
—
—
cases:1.12%
controls:0.26%
cases:2.28%
controls:0.96%
5
30
929
9281
—
0
5
935
9316
—
—
10
24
886
9057
18
76
773
7874
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 [3006999]
29374-6 [3006999]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.36%
—
—
—
—
—
—
12
29
779
7921
melatonin; oral
N05CH01 [21604659]
N05CH01 [21604659]
4.9e-01
2.8e-01
—
—
7.0e-01
8.2e-01
6.0e-01
cases:3.10%
controls:1.92%
cases:1.50%
controls:1.14%
—
—
—
—
cases:0.54%
controls:0.27%
cases:3.01%
controls:1.34%
cases:5.56%
controls:3.13%
29
179
905
9132
14
106
921
9215
—
—
5
25
920
9277
27
122
869
8959
44
249
747
7701
Incontinence urine
U04 [2002001139]
U04 [2002001139]
6.5e-01
—
—
—
—
—
1.4e+00
cases:0.54%
controls:0.28%
—
—
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.34%
5
26
929
9285
—
—
—
—
—
11
27
780
7923
Spinalanesthesia
WX320 [2001310799]
WX320 [2001310799]
5.1e-01
8.4e-01
—
1.0e+50
—
1.4e+00
6.1e-01
cases:3.75%
controls:2.29%
cases:1.60%
controls:0.70%
—
—
cases:0.75%
controls:0.00%
—
—
cases:2.46%
controls:0.62%
cases:4.17%
controls:2.31%
35
213
899
9098
15
65
920
9256
—
7
0
928
9321
—
22
56
874
9025
33
184
758
7766
mirtazapine; oral
N06AX11 [21604740]
N06AX11 [21604740]
3.9e-01
5.2e-01
-3.1e-03
—
7.6e-01
7.1e-01
6.8e-01
cases:7.17%
controls:4.96%
cases:4.49%
controls:2.71%
cases:0.86%
controls:0.86%
—
—
cases:1.62%
controls:0.76%
cases:5.13%
controls:2.60%
cases:11.63%
controls:6.28%
67
462
867
8849
42
253
893
9068
8
80
927
9241
—
15
71
910
9231
46
236
850
8845
92
499
699
7451
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
R5110 [2001310246]
4.4e-01
5.8e-01
—
—
—
1.4e+00
3.2e-01
cases:1.82%
controls:1.18%
cases:0.53%
controls:0.30%
—
—
—
—
—
—
cases:1.67%
controls:0.43%
cases:2.15%
controls:1.57%
17
110
917
9201
5
28
930
9293
—
—
—
15
39
881
9042
17
125
774
7825
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
2.9e-01
4.3e-01
5.4e-01
—
7.5e-01
4.7e-01
4.5e-01
cases:15.42%
controls:12.01%
cases:8.77%
controls:5.88%
cases:1.28%
controls:0.75%
—
—
cases:1.62%
controls:0.77%
cases:8.71%
controls:5.61%
cases:24.65%
controls:17.25%
144
1118
790
8193
82
548
853
8773
12
70
923
9251
—
15
72
910
9230
78
509
818
8572
195
1371
596
6579
mupirocin; nasal
R01AX06 [21603201]
R01AX06 [21603201]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.36%
—
—
—
—
—
—
11
29
780
7921
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
1.3e-01
7.8e-01
-1.0e+50
—
—
6.3e-01
5.6e-01
cases:5.78%
controls:5.11%
cases:3.42%
controls:1.60%
cases:0.00%
controls:0.13%
—
—
—
—
cases:2.90%
controls:1.56%
cases:8.98%
controls:5.31%
54
476
880
8835
32
149
903
9172
0
12
935
9309
—
—
26
142
870
8939
71
422
720
7528
Anxiety disorder/anxiety state
P74 [2002000868]
P74 [2002000868]
1.3e+00
—
—
—
—
—
9.5e-01
cases:1.50%
controls:0.40%
—
—
—
—
—
—
—
—
—
—
cases:1.52%
controls:0.59%
14
37
920
9274
—
—
—
—
—
12
47
779
7903
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
17791-5 [3027450]
—
—
—
—
—
—
1.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.64%
controls:0.44%
—
—
—
—
—
—
13
35
778
7915
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
EB1HA [2001301913]
1.8e-01
6.5e-01
—
—
—
2.7e-01
6.7e-01
cases:7.92%
controls:6.70%
cases:3.53%
controls:1.88%
—
—
—
—
—
—
cases:2.01%
controls:1.54%
cases:12.14%
controls:6.62%
74
624
860
8687
33
175
902
9146
—
—
—
18
140
878
8941
96
526
695
7424
fusidic acid
D09AA02 [21602265]
D09AA02 [21602265]
6.6e-01
5.3e-01
—
—
—
6.8e-01
6.5e-01
cases:4.71%
controls:2.49%
cases:1.50%
controls:0.89%
—
—
—
—
—
—
cases:1.90%
controls:0.97%
cases:5.94%
controls:3.19%
44
232
890
9079
14
83
921
9238
—
—
—
17
88
879
8993
47
254
744
7696
fusidic acid; ointment
D06AX01 [21602062]
D06AX01 [21602062]
6.6e-01
5.3e-01
—
—
—
6.8e-01
6.5e-01
cases:4.71%
controls:2.49%
cases:1.50%
controls:0.89%
—
—
—
—
—
—
cases:1.90%
controls:0.97%
cases:5.94%
controls:3.19%
44
232
890
9079
14
83
921
9238
—
—
—
17
88
879
8993
47
254
744
7696
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
1.3e+00
6.3e-01
—
—
—
8.2e-01
4.4e-01
cases:2.03%
controls:0.56%
cases:0.64%
controls:0.34%
—
—
—
—
—
—
cases:0.89%
controls:0.40%
cases:2.02%
controls:1.31%
19
52
915
9259
6
32
929
9289
—
—
—
8
36
888
9045
16
104
775
7846
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
3.1e-02
2.1e-01
-2.0e-02
—
1.3e+00
4.7e-01
3.5e-01
cases:4.28%
controls:4.16%
cases:2.78%
controls:2.27%
cases:0.64%
controls:0.65%
—
—
cases:1.41%
controls:0.39%
cases:3.57%
controls:2.27%
cases:7.46%
controls:5.37%
40
387
894
8924
26
212
909
9109
6
61
929
9260
—
13
36
912
9266
32
206
864
8875
59
427
732
7523
Insertion of (intrauterine) contraceptive device
Z30.1 [45537626]
Z30.1 [45537626]
3.7e-01
—
—
—
-1.0e+50
1.3e+00
4.0e-01
cases:1.50%
controls:1.04%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.23%
controls:0.34%
cases:2.53%
controls:1.71%
14
97
920
9214
—
—
—
0
6
925
9296
11
31
885
9050
20
136
771
7814
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
1.0e-01
—
—
1.0e+50
—
—
1.3e+00
cases:0.86%
controls:0.77%
—
—
—
—
cases:0.53%
controls:0.00%
—
—
—
—
cases:1.64%
controls:0.47%
8
72
926
9239
—
—
5
0
930
9321
—
—
13
37
778
7913
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
3.1e-01
2.9e-01
4.3e-01
—
6.6e-01
4.5e-01
4.8e-01
cases:18.09%
controls:13.98%
cases:11.12%
controls:8.54%
cases:2.67%
controls:1.75%
—
—
cases:3.14%
controls:1.64%
cases:13.06%
controls:8.72%
cases:28.19%
controls:19.58%
169
1302
765
8009
104
796
831
8525
25
163
910
9158
—
29
153
896
9149
117
792
779
8289
223
1557
568
6393
vortioxetine; oral
N06AX26 [44819158]
N06AX26 [44819158]
8.7e-01
1.0e+00
—
—
1.3e+00
1.2e+00
7.2e-01
cases:1.50%
controls:0.63%
cases:1.07%
controls:0.39%
—
—
—
—
cases:0.54%
controls:0.15%
cases:1.45%
controls:0.43%
cases:2.02%
controls:0.99%
14
59
920
9252
10
36
925
9285
—
—
5
14
920
9288
13
39
883
9042
16
79
775
7871
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
5.5e-01
6.4e-01
—
—
—
1.2e+00
6.3e-01
cases:2.89%
controls:1.69%
cases:1.07%
controls:0.57%
—
—
—
—
—
—
cases:1.45%
controls:0.43%
cases:3.29%
controls:1.77%
27
157
907
9154
10
53
925
9268
—
—
—
13
39
883
9042
26
141
765
7809
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
-1.7e-02
-1.3e-01
6.0e-01
—
1.2e+00
2.6e-01
1.2e-01
cases:12.74%
controls:12.93%
cases:5.88%
controls:6.65%
cases:1.60%
controls:0.89%
—
—
cases:1.95%
controls:0.58%
cases:8.37%
controls:6.61%
cases:19.97%
controls:18.06%
119
1204
815
8107
55
620
880
8701
15
83
920
9238
—
18
54
907
9248
75
600
821
8481
158
1436
633
6514
Treatment of a patient needing special arrangements
WYA30 [2001310874]
WYA30 [2001310874]
2.2e-01
9.2e-01
-1.0e+50
—
—
1.2e+00
1.2e+00
cases:1.50%
controls:1.20%
cases:0.75%
controls:0.30%
cases:0.00%
controls:0.05%
—
—
—
—
cases:1.00%
controls:0.30%
cases:3.03%
controls:0.92%
14
112
920
9199
7
28
928
9293
0
5
935
9316
—
—
9
27
887
9054
24
73
767
7877
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
1.2e+00
1.2e+00
—
—
—
6.3e-01
8.7e-02
cases:1.61%
controls:0.48%
cases:0.75%
controls:0.24%
—
—
—
—
—
—
cases:0.56%
controls:0.30%
cases:1.14%
controls:1.04%
15
45
919
9266
7
22
928
9299
—
—
—
5
27
891
9054
9
83
782
7867
Generalized anxiety disorder
F41.1 [45571764]
F41.1 [45571764]
1.2e+00
—
-1.0e+50
—
-1.0e+50
7.9e-01
4.9e-01
cases:1.28%
controls:0.39%
—
—
cases:0.00%
controls:0.05%
—
—
cases:0.00%
controls:0.08%
cases:0.56%
controls:0.25%
cases:1.26%
controls:0.78%
12
36
922
9275
—
0
5
935
9316
—
0
7
925
9295
5
23
891
9058
10
62
781
7888
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
M51.1 [45562747]
5.9e-01
1.2e+00
—
—
—
3.7e-01
5.9e-01
cases:2.57%
controls:1.44%
cases:1.71%
controls:0.53%
—
—
—
—
—
—
cases:0.67%
controls:0.46%
cases:2.91%
controls:1.64%
24
134
910
9177
16
49
919
9272
—
—
—
6
42
890
9039
23
130
768
7820
carbamazepine; oral, rectal
N03AF01 [21604417]
N03AF01 [21604417]
—
—
—
—
-1.0e+50
7.1e-01
1.2e+00
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.12%
cases:0.78%
controls:0.39%
cases:1.64%
controls:0.52%
—
—
—
—
0
11
925
9291
7
35
889
9046
13
41
778
7909
Paraesthesia of skin
R20.2 [45568120]
R20.2 [45568120]
3.1e-02
—
—
—
—
—
1.2e+00
cases:0.64%
controls:0.62%
—
—
—
—
—
—
—
—
—
—
cases:2.02%
controls:0.64%
6
58
928
9253
—
—
—
—
—
16
51
775
7899
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
1.2e+00
6.5e-01
-1.0e+50
—
—
4.6e-01
5.1e-01
cases:1.39%
controls:0.44%
cases:0.53%
controls:0.28%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.56%
controls:0.35%
cases:1.90%
controls:1.14%
13
41
921
9270
5
26
930
9295
0
6
935
9315
—
—
5
32
891
9049
15
91
776
7859
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
352
2358
1.78
15.42
2.5
2.2
248.60
270.47
u/l
0.16
336
2252
33
74
4.58
13.86
1.4
1.7
1.80
1.09
promille
1.58
23
62
206
1257
1.81
11.91
2.5
1.9
1.53
1.46
%
0.63
177
1117
349
2474
1.64
11.67
3.2
2.7
52.26
62.37
u/l
2.64
325
2316
451
3450
1.58
10.74
13.0
12.2
1.20
1.22
inr
0.23
374
2869
438
3332
1.58
10.66
5.0
5.3
35.12
36.28
g/l
3.40
400
3152
135
764
1.89
9.81
2.9
2.5
0.21
0.21
g/l
0.03
121
712
183
1147
1.74
9.48
1.8
1.7
1249.22
1146.72
nmol/l
0.72
143
897
92
471
2.05
8.91
3.2
1.6
0.28
0.35
mg/l
0.93
58
224
511
4135
1.50
8.72
6.6
6.7
10.39
11.65
umol/l
2.83
477
3942
198
1312
1.64
8.24
2.2
2.0
—
—
—
0
0
474
3810
1.48
8.15
9.2
7.7
1.21
1.21
mmol/l
0.24
416
3317
618
5249
1.50
7.98
6.1
4.3
1163.13
1325.48
e6/l
—
8
73
564
4716
1.47
7.79
8.3
5.4
6.69
6.62
mmol/l
0.27
533
4429
275
2006
1.52
7.47
2.9
2.4
—
—
—
0
0
127
768
1.75
7.38
4.7
3.2
—
—
—
0
0
33
115
2.94
7.38
9.8
5.7
11.92
10.99
mg/l
0.42
28
106
668
5819
1.48
7.18
4.6
3.4
52.68
47.33
u/l
0.41
635
5552
471
3842
1.44
7.17
3.5
2.8
—
—
estimate
—
0
0
127
783
1.72
6.89
4.7
4.2
1.70
1.68
mmol/l
0.02
111
675
424
3413
1.43
6.82
9.7
7.2
1.21
1.21
mmol/l
0.54
397
3166
73
380
2.00
6.77
6.5
4.1
53.39
49.78
%
0.57
73
373
371
2925
1.44
6.64
4.5
3.5
31.02
71.89
ng/l
0.98
248
1932
99
574
1.81
6.63
2.2
2.4
4.59
8.64
ug/l
3.43
90
522
23
70
3.34
6.44
1.7
1.5
—
—
—
0
0
309
2369
1.45
6.38
4.8
3.6
0.00
0.01
estimate
1.15
106
843
86
488
1.84
6.18
4.8
3.7
130.91
130.37
g/l
0.08
86
475
77
423
1.89
6.12
5.4
3.2
0.59
0.61
%
0.32
77
423
328
2566
1.42
5.99
3.9
3.2
167.51
80.31
e6/l
0.31
257
1939
236
1758
1.45
5.56
2.8
2.6
13.33
5.30
e6/l
0.56
215
1592
863
8073
1.67
5.54
22.2
14.6
23.61
23.57
mg/l
0.01
739
6606
358
2878
1.39
5.47
3.4
3.4
39.85
32.92
u/l
0.53
330
2738
208
1521
1.47
5.38
1.7
1.7
406.84
33900035.70
pmol/l
1.64
177
1295
673
6008
1.40
5.30
9.3
8.2
80.00
78.48
u/l
0.39
638
5733
62
333
1.92
5.30
5.5
3.7
24.98
25.08
mmol/l
0.10
62
318
144
981
1.55
5.21
2.1
1.8
—
—
—
0
0
132
883
1.57
5.18
15.6
9.6
1.10
0.84
mmol/l
0.38
111
732
137
926
1.56
5.14
2.2
1.9
—
—
—
0
0
133
893
1.57
5.13
15.5
9.6
5.18
5.13
kpa
0.31
127
855
133
893
1.57
5.13
15.5
9.6
12.41
12.34
kpa
0.05
127
859
509
4365
1.35
5.04
4.4
3.5
0.00
0.00
estimate
-0.00
119
911
175
1252
1.49
5.03
2.5
2.5
2.32
2.33
g/l
0.10
163
1159
515
4429
1.35
4.98
4.4
3.6
8.96
0.37
estimate
0.47
112
847
162
1146
1.50
4.92
2.6
2.6
23.58
23.68
%
0.03
152
1072
512
4405
1.35
4.91
4.4
3.5
21.32
6.90
estimate
0.45
121
911
659
5908
1.37
4.74
4.7
4.1
12.23
10.41
mm/h
1.93
625
5555
282
2223
1.38
4.72
3.9
3.1
0.79
0.41
e6/l
0.95
213
1605
182
1329
1.46
4.70
2.5
2.5
13.54
13.82
umol/l
0.17
170
1230
72
422
1.76
4.69
1.6
1.4
—
—
—
0
0
240
1853
1.39
4.53
2.2
1.9
1.72
1.21
mg/l
0.31
173
1408
31
136
2.32
4.49
5.7
6.2
346.84
377.57
umol/l
0.47
31
119
180
1329
1.44
4.37
4.1
3.8
0.81
0.82
mmol/l
1.12
170
1273
851
8014
1.54
4.36
25.5
16.9
3.98
3.96
mmol/l
0.66
837
7840
16
50
3.24
4.35
2.7
3.2
7.64
8.42
mmol/l
0.35
16
50
850
8007
1.53
4.30
25.5
16.8
139.44
139.62
mmol/l
1.65
840
7854
43
220
2.00
4.27
2.0
1.6
—
—
—
0
0
273
2174
1.36
4.22
1.8
1.6
18.81
19.87
nmol/l
0.66
233
1852
15
46
3.30
4.20
2.7
4.8
112.17
131.17
umol/l
—
6
29
396
3335
1.32
4.17
2.4
2.0
94.18
95.08
pmol/l
0.14
225
1865
643
5800
1.33
4.08
3.6
3.4
—
—
—
0
0
46
248
1.90
3.95
5.6
4.2
1.48
1.34
mmol/l
0.31
46
241
393
3325
1.31
3.95
4.3
3.4
0.01
0.02
estimate
0.60
102
760
535
4720
1.30
3.91
11.6
9.8
4.11
4.08
e9/l
0.09
461
4108
255
2035
1.34
3.85
5.8
4.2
88.36
90.12
%
0.57
250
1999
310
2556
1.31
3.71
2.5
3.3
2.33
2.35
mmol/l
1.93
277
2348
78
500
1.61
3.69
22.8
12.7
0.71
0.65
%
0.63
78
495
683
6257
1.32
3.62
4.3
4.1
14.59
14.62
pmol/l
0.11
627
5762
246
1975
1.33
3.53
4.2
3.5
1.02
1.02
kg/l
0.27
165
1283
412
3547
1.28
3.51
2.5
2.5
76.06
73.79
nmol/l
0.78
374
3247
49
282
1.78
3.46
1.8
1.8
—
—
—
0
0
78
511
1.57
3.39
1.1
1.0
—
—
—
0
0
7
10
7.04
3.36
1.0
1.1
—
—
—
0
0
7
10
7.04
3.36
1.0
1.1
—
—
—
0
0
13
43
3.05
3.26
2.8
2.2
112.15
139.65
nmol/l
0.69
13
37
160
1217
1.38
3.25
2.7
2.4
30.53
29.41
s
1.22
154
1185
41
228
1.83
3.25
1.5
1.3
—
—
—
0
0
85
574
1.53
3.24
2.0
1.6
—
—
—
0
0
261
2143
1.30
3.15
2.5
2.2
2.78
2.73
mg/l
0.13
229
1857
51
306
1.70
3.14
1.8
1.9
—
—
—
0
0
257
2108
1.30
3.12
3.5
3.4
1830.24
1186.40
ng/l
0.48
212
1766
51
308
1.69
3.07
2.1
2.0
2.30
2.34
ug/l
0.01
43
271
37
203
1.86
3.07
2.7
1.5
61.96
13.75
e6/l
0.82
27
145
77
516
1.54
3.05
23.3
12.4
1.78
1.29
%
2.68
77
510
35
189
1.88
3.05
3.3
3.3
1.40
1.48
mmol/l
0.21
35
183
777
7312
1.33
2.98
6.2
5.9
39.05
38.70
mmol/mol
0.46
743
6939
37
206
1.83
2.94
5.9
4.2
3.76
3.92
mmol/l
1.67
37
201
881
8465
1.48
2.94
13.7
11.3
27.73
27.61
u/l
0.07
866
8270
37
207
1.82
2.90
2.8
1.5
402.29
1027.97
e6/l
0.43
31
156
185
1469
1.32
2.83
5.0
3.8
119.17
537.73
ng/l
3.62
126
1058
174
1373
1.33
2.78
3.8
2.8
0.89
0.93
e6/l
0.09
96
710
11
34
3.26
2.73
5.6
1.5
—
—
—
0
0
22
107
2.08
2.59
1.6
1.7
—
—
—
0
0
784
7426
1.30
2.58
5.5
5.0
2.33
1.86
mu/l
0.51
732
6942
89
639
1.43
2.54
2.2
2.4
0.23
0.42
e6/l
0.58
84
610
18
82
2.22
2.48
1.4
2.4
28.20
18.87
mg/l
—
5
36
174
1396
1.30
2.47
2.2
2.8
2.43
2.44
mmol/l
0.48
152
1260
162
1290
1.31
2.43
3.8
2.9
3.95
2.17
e6/l
0.95
83
629
37
220
1.71
2.41
1.5
1.4
307.54
289.62
ug/g
0.19
26
129
9
27
3.35
2.39
1.9
3.4
5.37
4.85
kpa
—
9
27
9
27
3.35
2.39
1.9
3.4
10.01
10.47
kpa
—
9
27
81
579
1.44
2.38
3.6
3.8
1.22
1.22
mmol/l
0.45
69
494
28
154
1.84
2.36
2.4
1.5
—
—
—
0
0
72
506
1.46
2.32
3.8
3.5
1.89
1.56
mmol/l
0.48
55
370
796
7594
1.28
2.20
19.6
13.7
88.07
86.92
ml/min/173m2
0.77
746
6948
10
36
2.80
2.14
2.0
2.3
—
—
—
0
0
178
1459
1.27
2.14
2.4
2.2
—
—
—
0
0
13
55
2.38
2.12
1.4
1.3
19.09
35.19
nmol/l
1.41
13
48
67
475
1.44
2.08
2.1
1.6
—
—
—
0
0
49
326
1.53
2.08
1.5
1.7
10.86
8.70
u/ml
—
10
81
105
805
1.34
2.06
2.5
2.5
36.43
91.71
u/l
0.45
77
686
6
15
4.02
2.04
1.2
1.3
—
—
—
0
0
68
486
1.43
2.03
2.8
2.3
2962.92
5845.91
u/l
0.62
31
209
778
7423
1.25
2.01
4.1
4.0
1.26
1.29
mmol/l
0.64
728
6951
11
44
2.52
2.01
1.1
1.1
—
—
—
0
0
8
27
2.98
1.94
11.0
4.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
228
1.60
1.90
2.6
3.4
0.38
0.37
iu/ml
0.08
16
114
132
1059
1.29
1.89
6.7
6.7
1.04
1.04
mmol/l
0.04
123
997
787
7536
1.24
1.86
5.0
4.6
5.95
5.88
mmol/l
0.67
726
6991
13
59
2.22
1.84
1.0
1.0
1896.85
1465.25
miu/ml
0.68
13
59
15
73
2.07
1.81
1.1
1.0
—
—
—
0
0
101
789
1.31
1.77
8.0
6.5
—
—
—
0
0
15
74
2.04
1.75
2.3
2.9
—
—
—
0
0
187
1578
1.23
1.74
2.5
2.3
—
—
—
0
0
20
110
1.84
1.74
1.7
1.7
—
—
—
0
0
38
252
1.53
1.68
1.2
1.2
—
1.88
—
0
10
309
2745
1.19
1.67
4.2
3.4
7.79
8.33
mmol/l
1.11
270
2367
46
318
1.47
1.67
1.9
1.7
—
—
—
0
0
119
959
1.27
1.66
2.7
3.0
6.33
8.27
umol/l
0.94
99
843
11
50
2.21
1.57
1.1
1.4
—
21.00
—
0
8
10
44
2.29
1.56
1.3
1.4
—
—
—
0
0
10
44
2.29
1.56
1.3
1.4
—
—
—
0
0
76
582
1.33
1.55
1.6
1.5
—
—
—
0
0
820
7925
1.24
1.54
5.4
5.2
2.71
2.73
mmol/l
0.25
771
7465
112
906
1.27
1.53
4.6
4.4
30.98
31.41
%
0.15
82
628
24
146
1.66
1.52
1.4
1.3
—
—
—
0
0
24
146
1.66
1.52
1.4
1.3
—
—
—
0
0
143
1195
1.23
1.47
2.2
2.8
153.99
114.96
ug/g
0.37
118
967
246
2166
1.18
1.46
1.5
1.3
1.61
1.86
u/ml
0.18
76
623
75
583
1.31
1.40
1.4
3.1
66.38
67.10
g/l
0.36
65
540
7
29
2.42
1.39
1.1
1.0
—
—
—
0
0
279
2494
1.17
1.37
4.0
3.0
0.00
0.05
estimate
0.78
100
726
36
248
1.47
1.37
1.3
1.3
—
—
—
0
0
33
225
1.48
1.32
1.4
1.7
—
—
—
0
0
449
4166
1.15
1.32
3.4
3.2
122.10
118.85
ug/l
0.14
416
3926
17
98
1.75
1.31
1.1
1.1
—
—
—
0
0
30
201
1.51
1.31
1.3
1.2
—
—
—
0
0
233
2062
1.17
1.30
2.3
2.8
347.34
345.60
umol/l
0.09
207
1849
67
519
1.31
1.30
3.1
3.1
205.68
200.31
ng/l
0.03
62
464
11
55
2.01
1.27
1.8
1.6
2.34
1.25
nmol/l
—
5
41
28
187
1.51
1.25
1.3
1.2
—
1.30
—
0
10
6
25
2.41
1.24
1.0
1.1
—
—
—
0
0
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
23
148
1.57
1.21
1.6
1.9
—
—
—
0
0
218
1931
1.17
1.20
1.5
1.5
2.69
2.35
g/l
1.83
143
1237
27
181
1.51
1.19
1.8
1.7
—
—
—
0
0
46
342
1.36
1.18
1.5
2.0
1.48
1.44
g/l
0.11
40
308
903
8866
1.30
1.17
31.8
22.1
255.45
250.10
e9/l
1.56
892
8725
34
240
1.43
1.17
1.4
1.7
—
—
—
0
0
11
57
1.94
1.17
1.9
1.8
—
—
—
0
0
15
87
1.74
1.15
1.1
1.1
—
—
—
0
0
5
20
2.51
1.15
1.0
1.4
1.18
1.18
mmol/l
—
5
20
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
808
7848
1.18
1.15
4.9
4.7
4.58
4.59
mmol/l
0.13
763
7424
105
875
1.22
1.14
4.1
4.8
234.35
248.37
u/l
0.61
96
836
804
7809
1.18
1.13
4.8
4.6
1.42
1.41
mmol/l
0.12
758
7346
903
8871
1.29
1.12
33.5
22.6
40.50
40.90
%
1.84
898
8791
903
8871
1.29
1.12
31.8
22.0
4.49
4.56
e12/l
4.33
889
8710
66
524
1.28
1.09
3.0
3.7
4.75
4.64
pmol/l
0.20
55
468
903
8876
1.28
1.07
32.1
22.2
135.17
137.30
g/l
4.12
898
8800
110
928
1.21
1.07
2.6
2.2
—
—
—
0
0
32
228
1.42
1.07
1.3
1.1
—
—
—
0
0
32
228
1.42
1.07
1.3
1.1
—
—
—
0
0
902
8868
1.27
1.04
31.8
22.0
90.98
90.57
fl
1.84
897
8797
5
22
2.28
1.03
2.2
2.3
10.58
14.45
umol/l
—
5
22
58
458
1.28
1.02
1.3
1.5
20.81
20.46
iu/l
0.02
44
386
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
48
1.88
1.00
1.2
1.1
—
—
—
0
0
7
35
2.01
1.00
1.0
1.4
—
—
—
0
0
7
35
2.01
1.00
1.0
1.0
—
—
—
0
0
7
35
2.01
1.00
1.0
1.4
—
—
—
0
0
23
156
1.49
0.99
3.4
3.4
7.42
7.55
mmol/l
0.08
23
151
7
36
1.95
0.97
2.3
1.1
—
—
—
0
0
9
50
1.81
0.96
2.6
1.6
—
—
—
0
0
13
77
1.70
0.95
1.3
1.1
—
79.00
—
0
6
27
192
1.42
0.93
1.2
2.2
0.93
0.86
nmol/l
0.15
16
170
30
220
1.38
0.88
3.9
3.3
3.07
2.09
index
0.21
15
128
35
265
1.33
0.85
2.3
3.0
—
—
—
0
0
13
80
1.63
0.85
1.1
1.1
17.13
17.75
u/ml
—
7
38
6
31
1.94
0.84
2.5
1.1
—
—
—
0
0
157
1398
1.15
0.83
1.3
1.3
7.51
10.69
u/ml
0.27
64
548
20
138
1.46
0.82
1.2
1.1
—
1.61
—
0
8
6
32
1.88
0.82
1.2
1.1
28.78
42.63
u/ml
—
6
32
19
130
1.47
0.81
1.0
1.1
1.89
2.21
—
5
26
91
780
1.18
0.79
2.3
2.1
—
—
—
0
0
14
90
1.56
0.78
18.4
1.7
—
—
—
0
0
59
486
1.23
0.77
1.5
1.3
—
—
—
0
0
6
34
1.77
0.76
1.2
1.2
19.17
16.00
u/l
—
6
27
46
370
1.26
0.74
1.4
1.6
9.48
8.01
u/l
0.36
35
305
5
25
2.01
0.72
1.0
1.1
—
—
—
0
0
23
310
0.74
0.72
1.6
1.6
—
—
—
0
0
35
273
1.29
0.72
1.3
1.3
—
—
—
0
0
11
68
1.62
0.72
1.1
1.1
—
—
—
0
0
7
40
1.76
0.71
1.1
2.8
—
55726.63
—
0
8
72
616
1.18
0.66
2.9
2.6
70.00
70.81
ml/min/173m2
0.06
33
270
5
29
1.73
0.64
2.2
1.8
—
—
—
0
0
45
370
1.23
0.62
1.2
1.4
—
—
—
0
0
14
96
1.47
0.61
1.4
1.4
—
—
—
0
0
70
606
1.17
0.58
1.4
1.3
147.16
262.08
u/ml
1.08
65
559
207
1925
1.10
0.55
1.8
1.7
—
—
—
0
0
23
294
0.78
0.54
2.7
3.6
630.56
4441.31
u/ml
0.58
18
253
9
61
1.48
0.53
1.0
1.2
124.56
103.56
pmol/l
—
9
61
13
91
1.43
0.53
3.1
2.6
103.92
105.40
mmol/l
0.31
13
91
13
91
1.43
0.53
3.1
2.6
3.84
4.04
mmol/l
0.58
13
91
6
39
1.54
0.53
1.7
2.9
1.00
1.23
%
—
6
39
12
83
1.45
0.52
1.2
1.1
—
—
—
0
0
11
76
1.45
0.48
6.2
4.2
13.00
12.94
index
—
6
54
7
47
1.49
0.47
1.1
2.0
—
—
—
0
0
7
47
1.49
0.47
1.1
2.0
—
—
—
0
0
717
7028
1.08
0.46
25.9
18.1
332.59
333.54
g/l
2.27
709
6996
14
104
1.35
0.43
1.2
1.5
—
—
—
0
0
162
1509
1.09
0.43
1.4
1.3
27.87
27.59
iu/ml
0.01
41
436
30
249
1.21
0.42
1.2
1.1
1.77
9.13
eliau/ml
—
6
36
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
8
59
1.36
0.41
1.3
3.0
815.88
1256.42
mg
—
8
59
58
655
0.88
0.40
1.6
1.6
1002.67
970.39
mu/l
0.12
49
555
40
343
1.17
0.40
1.1
1.1
0.69
0.64
ratio
—
8
33
5
35
1.43
0.39
1.2
1.1
0.28
0.28
g/l
—
5
29
10
71
1.41
0.39
1.8
2.3
32.20
37.06
mg/l
—
5
52
14
106
1.33
0.39
1.3
1.5
—
—
—
0
0
14
106
1.33
0.39
1.3
1.5
—
—
—
0
0
18
142
1.27
0.38
1.3
2.0
—
2306.67
—
0
6
5
36
1.39
0.38
1.0
1.2
101.80
105.26
%
—
5
31
60
534
1.13
0.38
3.5
4.4
81.76
84.17
ng/l
0.06
51
480
12
89
1.35
0.38
1.2
1.9
—
—
—
0
0
12
89
1.35
0.38
3.3
2.6
1.19
1.19
mmol/l
0.02
12
89
65
583
1.12
0.37
2.5
2.4
20.87
14.96
au/ml
—
6
66
19
234
0.81
0.36
1.8
1.5
—
—
—
0
0
20
162
1.24
0.35
1.2
1.6
—
—
—
0
0
6
42
1.43
0.35
1.0
1.2
—
88.43
%
—
0
7
13
100
1.30
0.33
1.2
1.9
—
—
—
0
0
101
934
1.09
0.33
2.5
2.4
14.99
13.34
nmol/l
1.01
90
855
27
229
1.18
0.32
1.4
1.3
217.44
244.35
u/ml
0.26
16
134
6
47
1.28
0.32
1.0
1.1
1.11
1.07
ratio
—
6
41
38
433
0.87
0.32
1.5
1.5
—
—
—
0
0
29
248
1.17
0.32
1.1
1.1
3.55
4.45
—
6
37
23
273
0.84
0.31
1.7
1.8
—
—
—
0
0
24
202
1.19
0.31
1.2
1.5
—
—
—
0
0
24
203
1.19
0.30
1.3
1.4
—
—
—
0
0
41
363
1.14
0.30
1.1
1.1
1.49
1.51
g/l
0.20
41
363
18
148
1.22
0.29
1.4
1.2
1.71
3.06
u/ml
—
7
54
22
185
1.19
0.29
1.7
1.6
33483.65
11262.21
e6/l
0.44
17
135
32
366
0.87
0.29
2.8
1.9
2.62
3.43
mg/l
0.45
24
263
34
298
1.15
0.28
1.7
1.5
0.09
0.12
iu/ml
—
9
48
8
62
1.29
0.28
1.1
1.2
—
—
—
0
0
18
149
1.21
0.28
1.4
1.2
1.80
3.40
u/ml
—
10
68
8
63
1.27
0.27
1.3
1.7
—
—
—
0
0
8
64
1.25
0.27
2.1
2.5
294.25
228.98
e6/l
—
8
55
167
1753
0.94
0.27
3.0
3.0
0.70
0.74
ug/l
0.32
100
1040
58
635
0.91
0.27
1.2
1.3
68.91
151.37
u/ml
2.37
15
254
17
204
0.83
0.27
1.0
1.1
1.08
2.43
u/ml
—
8
114
9
72
1.25
0.25
2.0
1.2
—
—
—
0
0
9
73
1.24
0.25
1.2
1.5
257.44
175.76
pmol/l
—
9
73
9
73
1.24
0.25
2.0
1.2
—
—
—
0
0
17
202
0.84
0.25
1.4
4.1
1.64
2.44
ratio
0.82
11
118
87
813
1.08
0.24
1.6
1.7
3.53
3.45
mmol/l
0.30
55
585
20
170
1.18
0.24
1.1
1.1
7.87
13.32
au/ml
—
7
54
19
161
1.18
0.24
1.5
1.5
—
—
—
0
0
31
349
0.88
0.24
1.7
1.5
1.04
1.19
ratio
0.37
14
219
31
349
0.88
0.24
1.7
1.5
1.10
1.23
ratio
0.26
14
219
31
349
0.88
0.24
1.7
1.5
0.91
0.94
ratio
0.21
14
219
20
233
0.86
0.24
1.0
1.1
1.07
3.61
u/ml
1.52
11
131
300
2913
1.04
0.23
5.1
5.0
2.79
2.20
ug/l
0.32
267
2647
20
232
0.86
0.23
1.3
1.6
41.08
55.08
ug/l
1.98
20
232
12
97
1.24
0.23
1.1
1.3
—
—
—
0
0
116
1223
0.94
0.23
1.6
1.5
—
—
—
0
0
13
157
0.83
0.22
1.8
1.5
—
—
—
0
0
5
40
1.25
0.22
1.0
1.5
3.16
6.27
nmol/l
—
5
35
339
3304
1.04
0.22
2.0
1.9
1.37
1.38
mmol/l
0.07
277
2842
251
2434
1.04
0.21
4.3
4.2
15.98
10.38
mg/mmol
0.66
161
1588
6
49
1.23
0.20
1.2
1.2
—
—
—
0
0
16
137
1.17
0.19
1.4
1.1
—
—
—
0
0
114
1088
1.05
0.19
1.8
1.9
3.53
3.54
ratio
0.02
80
850
42
387
1.09
0.18
1.2
1.4
254.72
237.61
miu/ml
0.10
20
199
7
61
1.15
0.17
1.1
1.5
80.86
78.70
umol/l
—
7
61
20
226
0.88
0.17
2.9
2.3
13.51
11.51
mg/l
0.76
20
211
16
184
0.87
0.17
1.6
1.2
—
—
—
0
0
31
339
0.91
0.16
1.7
1.5
—
—
—
0
0
11
92
1.20
0.16
1.0
1.2
—
—
—
0
0
8
73
1.10
0.15
1.0
2.2
—
—
—
0
0
17
149
1.14
0.15
1.4
1.1
1.28
2.34
eliau/ml
—
10
63
9
79
1.14
0.15
2.6
3.3
6.77
5.27
nmol/l
—
9
79
33
358
0.92
0.15
1.8
1.9
—
—
—
0
0
21
188
1.12
0.15
2.6
2.4
86.08
91.28
ug/min
0.05
12
109
28
259
1.08
0.11
1.5
1.4
—
—
—
0
0
229
2336
0.97
0.11
4.4
4.2
20.64
21.21
%
0.26
103
1015
38
358
1.06
0.10
1.9
2.0
11.80
7.49
iu/ml
—
5
86
26
241
1.08
0.10
1.2
2.7
9.81
10.68
g/l
0.63
20
222
5
44
1.14
0.10
1.6
1.7
—
—
—
0
0
12
135
0.89
0.10
1.3
1.6
—
—
—
0
0
5
45
1.11
0.10
1.6
1.7
—
—
—
0
0
14
155
0.90
0.09
4.4
3.2
7.69
8.33
pmol/l
0.23
14
155
6
54
1.11
0.09
7.3
4.5
0.67
1.02
index
—
6
54
5
62
0.81
0.08
1.4
1.5
0.50
0.48
e9/l
—
5
62
7
66
1.06
0.08
1.9
2.3
490.71
632.23
e6/l
—
7
53
26
244
1.07
0.08
2.4
2.1
17.61
4.23
iu/l
—
9
99
6
73
0.82
0.07
1.5
1.6
—
—
—
0
0
7
81
0.86
0.07
1.4
1.3
—
88.20
—
0
5
7
82
0.85
0.07
1.4
1.1
—
—
—
0
0
8
92
0.87
0.06
1.4
1.2
—
—
—
0
0
11
101
1.09
0.04
1.4
1.5
—
—
—
0
0
11
101
1.09
0.04
1.4
1.5
—
—
—
0
0
36
372
0.97
0.04
1.7
1.6
57.50
61.47
ug/l
0.21
28
315
16
151
1.06
0.03
2.3
3.7
—
2903.13
—
0
15
18
189
0.95
0.03
1.3
1.3
—
—
—
0
0
11
102
1.08
0.03
1.4
1.5
—
—
—
0
0
12
112
1.07
0.03
1.3
1.4
—
—
—
0
0
67
681
0.98
0.02
3.1
4.6
3.53
28.66
ug/l
1.36
56
568
16
153
1.05
0.01
1.3
1.3
—
—
—
0
0
17
163
1.04
0.01
1.2
1.1
18.58
97.42
iu/ml
—
5
38
11
104
1.06
0.01
1.2
1.4
167.06
416.24
pmol/l
3.40
11
93
10
106
0.94
0.01
1.6
1.2
92.70
94.62
%
—
10
97
12
114
1.05
0.00
1.0
1.0
—
—
—
0
0
16
154
1.04
0.00
1.1
1.1
—
—
—
0
0
19
184
1.03
0.00
1.9
1.9
—
—
—
0
0
28
274
1.02
0.00
1.2
2.6
2.91
2.96
g/l
0.11
23
256
10
104
0.96
0.00
1.5
1.4
0.63
0.58
nmol/l
—
10
98
12
116
1.03
0.00
1.1
1.2
—
—
—
0
0
17
174
0.98
0.00
1.2
1.5
—
—
—
0
0
39
392
0.99
0.00
2.1
1.9
43.79
38.28
nmol/l
0.52
39
378
10
97
1.03
0.00
1.2
2.5
15.10
23.29
nmol/l
—
10
90
29
287
1.01
0.00
1.2
2.6
7.61
7.18
g/l
0.53
24
269
29
287
1.01
0.00
1.2
2.6
4.17
3.70
g/l
1.26
24
269
29
287
1.01
0.00
1.2
2.6
4.28
4.22
g/l
0.15
24
269
697
6971
1.00
0.00
26.7
17.9
13.64
13.47
%
3.23
689
6900
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
0.00
1.6
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
5
53
0.94
0.00
7.8
3.1
32.40
49.11
u/ml
—
5
53
0
6
0.00
-0.00
0.0
5.5
—
—
—
0
0
7
74
0.95
-0.00
1.0
1.7
—
—
—
0
0
7
74
0.95
-0.00
1.0
1.7
—
—
—
0
0
7
77
0.91
-0.00
1.3
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
74
0.95
-0.00
1.0
1.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
25
250
1.00
-0.00
1.2
2.9
0.24
1.04
g/l
1.53
19
227
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
74
0.95
-0.00
1.4
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
10.67
—
0
6
0
9
0.00
-0.00
0.0
2.9
—
0.44
—
0
9
7
76
0.92
-0.00
1.4
1.2
—
—
—
0
0
13
130
1.00
-0.00
1.5
1.2
126.46
111.27
%
1.48
13
120
7
76
0.92
-0.00
1.4
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.4
—
4.28
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
2.08
—
0
7
7
76
0.92
-0.00
3.3
3.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
0.09
—
0
9
5
54
0.93
-0.00
3.0
2.5
—
—
—
0
0
7
73
0.96
-0.00
1.4
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_BURN_CORROSION_HIP_LOWER_LIMB_ANKLE_FOOT – Burn and corrosion of hip and lower limb, except ankle and foot
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).